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Development of advanced techniques for biological network visualisation is crucial for 
successful progress in the areas of systems-level biology and data-intensive 
bioinformatics. 
However, current techniques for biological network visualisation fall short of 
expectations for representing extensive biological networks. In order to provide really 
useful network visualisation tools, new approaches have to be proposed and applied 
alongside with those most powerful features of current visualisation systems. The 
resulting representation techniques have to be tested by applying to large-scale examples 
that would include metabolic, signaling and gene expression events. User survey should 
also be carried out to further prove the advantages of the new techniques.  
The present thesis describes an attempt to achieve the above objectives, by performing 
the following steps: 1) existing approaches in the area of network representation were 
analyzed and their shortcomings and advantages were defined; 2) new notation has been 
developed, in which, the defined best features of the existing systems were integrated 
with newly introduced potent features such as compact visualization, ‘functional gate’ 
and ‘identity gate’, 4) new framework was developed that allows managing large-scale 
networks that are represented on different levels of details and different levels of 
constrains, while keeping each diagram semantically unambiguous, 5) extensive 
examples, including genome-scaled human metabolic network and TNF-alpha receptor 
signalling network, were used to prove that the designed notation and the framework can 
be applied efficiently, and, finally, 6) a notation survey has been carried out to validate 
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Motivation. Any ambitious project in the area of biological network visualisation 
requires a highly advanced environment in which biological knowledge could be 
comprehensively represented and stored in such way that information could be easily 
shared, updated and re-used. Despite noticeable progress in the area of Systems 
Biology, there is still a lack of effective approaches that would allow us to 
amalgamate all available information on biological networks in one powerful system. 
Furthermore, to demonstrate their effectiveness these approaches would have to be 
not only well-thought-through, but also supported by comprehensive and wide-
ranging examples. While developing these extensive test diagrams, the approaches 
should be modified if required. 
Objectives. The main objectives of this research are:  
1. To design a new system of symbols for unambiguous biological network 
visualisation. In order to do so a large number of the existing notations’ features have 
to be combined with newly introduced entities into a new notation. This notation is 
introduced in this work as the Unified Notation (UN). The diagrams in this notation 
have to be both human- and machine-readable. The Unified Notation should be able 
to represent all types of process description maps: metabolic pathways, signalling 
pathways, gene expression events, and maps combining these pathways.  
2. To develop a framework where a large scale network could be represented 
efficiently. For this purpose the thesis suggest (A) subdividing a large network into 
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comparatively small, manageable and easy-updatable diagrams that can be used and 
reused as elements for assembling large networks for a particular cell type and a 
particular organism; (B) developing an approach for creating a system that could 
represent a network on different levels of granularity; (C) developing a method that 
unites multiple detailed maps into a single virtual map. 
3. To test the newly developed notation and the framework using large-scale 
biological networks. This will ensure the system’s consistency and its ability to 
visualise many different types of networks. 
Software. Although the approach is developed to be used in many different editors 
thus accommodating all or some of the features proposed, to test the new features it is 
suggested using a tool (editor) that would meet the following requirements:  
• information on a map has to be both human and machine-readable, therefore 
properties of each object have to be stored in a database the software creates, 
so it could be potentially exported, imported, transformed into other formats or 
translated into other graphical languages if needed; in this way the software 
can be used as a data-sharing environment 
• it should be able to create/change/delete user-defined objects with user-defined 
properties, with the aim that the entities of new notation could be tested, added 
or removed; 
• it should be possible to use hyperlinks so that one map could be connected to 
another; 
• possibility to work in collaboration with software developers so new features 
could be introduced if necessary. 
All these requirements are met by the Edinburgh Pathway Editor (EPE) (Sorokin, 
2006) (EPE, http://epe.sourceforge.net/SourceForge/EPE.html) that facilitated the 
development of all the diagrams. Please see Section 2.6 for more details on the 
Edinburgh Pathway Editor. 
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It is of crucial importance that the research approaches were developed and tested 
relying not on one particular editor, but introduced as general methods that can be 
used for efficient biological network visualisation with any appropriate software. 
Development in the field since this research started. The work started in 2006 and 
since then there have been a number of significant developments in the area of 
graphical biological network representation. The most important of all was the 
initiation of the SBGN project, which was supported by scientists from many different 
fields . In many ways the notation part of this research overlaps with the efforts 
related to developing the SBGN PD language therefore a detailed comparison of the 
two notations is provided in Chapter 2. The experience of using the Unified Notation 
to represent metabolic and metabolism regulation pathways were utilised in the 
proposal presented at the COMBINE meeting in 2010 (COmputational Modeling in 
BIology Network, http://sbml.org/Events/Forums/COMBINE_2010, fore more details 
please see Chapter 9). 
 
 
Structure of the thesis  
Chapter 1 gives an account of the existing research in the field. 
Chapter 2 introduces the Unified Notation (UN). 
Chapter 3 describes the Network Representation Framework (NRF). 
Chapters 4 and 5 provide examples of using the novel approaches. Chapter 4: the 
Edinburgh Human Metabolic Network representation. Chapter 5: TNF-alpha receptor 
network representation. 
Chapter 6 summarizes results of the Graphical Notation Survey. 
Chapter 7 describes the features of the Unified Notation aiming at improving the 
SBGN PD language 
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All the necessary additional information is provided in the appendices and on the CD 
enclosed with each copy of the thesis. Given that the thesis contains some figures that 






Review of related work 
 
1.1 Human-Computer Interaction 
The size of current datasets and the scale of analyses required in biological science 
increasingly depend on computer-aided support. On the other hand, it is important that 
the computer-based tools provide adequate level of functionality while being 
convenient to use. In order to represent vast amounts of information in a meaningful 
and convenient way, the computer-based tools inevitably should use bleeding-edge 
features and paradigms (Keefe, 2010, Pettifer, 2009). The discipline that ‘concerned 
with the design, evaluation and implementation of interactive computing systems for 
human use and with the study of major phenomena surrounding them’ (ACM SIGCHI 
Curricula for Human-Computer Interaction, http://old.sigchi.org/cdg/ cdg2.html#2_1) 
is the area of Human Computer Interaction (HCI). 
Unfortunately there is no unified theory of HCI that currently could be presented (Dix 
et al, 2004; Sears, 2008; Zaphiris, 2009). In many ways this area is as much science as 
it is a craft and involves a lot of experimentation on the part of software developers, 
experts from linguistics, graphic designers and scientists from many different fields 
(Beaudouin-Lafon, 1993; Dix et al, 2004). 
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This section reviews the HCI conceptions that are applicable to the challenges related 
to biological networks visualisation. 
‘Usability’ is one of the main conceptions in HCI and initially was defined as ‘ease to 
use’, ‘user-friendliness’ and ‘easy to learn’ (Karat, 2003). This understanding is still 
widely accepted (Dix et al, 2004). The ‘ease of use’ is often one of the crucial 
parameters that would determine user decision whether to use a system or not. 
The following set of usability criteria is identified based on the analyses by Nielsen 





• Attitude/satisfaction (subjective component). 
• Reliability 
Shneiderman proposed usability as research agenda 
(http://universalusability.org/researchagenda) that includes the three issues listed 
below (Shneiderman, 2000):  
• Technology variety (“supporting a broad range of hardware, software, and 
network access” (http://universalusability.org/technologyvariety)); 
• User diversity (“accommodating users with different skills, knowledge, age, 
gender, disabilities, disabling conditions (mobility, sunlight, noise), literacy, 
culture, income, etc.” (http://universalusability.org/userdiversity)); 
• Gaps in user knowledge (“bridging the gap between what users know and 
what they need to know” (http://universalusability.org/gapsuserknowledge)). 
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In this research we define main criteria for usability as effectiveness, ease to use, ease 
to maintain, ease-to-learn and ability to bridge gaps in user knowledge.  
The newly developed notation satisfies the principle of maintainability by using 
comparatively small and easy to maintain low-level maps that form a library of 
‘building blocks’. These small maps are then used for building representations of 
large cellular networks (see Chapters 4 and 5). When underlying mini-maps are 
updated because the underlying metabolic process gets rectified, these changes are 
reflected in the large maps. Therefore, updating a mini-map in only one place saves 
great amount of work on maintaining such maps. 
Ease-to-learn criteria is satisfied by using a notation with minimal number of symbols 
that are easy to remember (see Section 8.7.11). Many of these symbols are similar to 
those used in other notations, such as SBGN, which makes cross-learning much 
easier. At the same time the used set of symbols remains being sufficient for 
unambiguous cellular network representation (effectiveness criteria) (see Sections 
6.5.9).  
Human limitations in processing of information have important implication for design 
(Dix et al, 2004; Olson, 2003; Sears, 2008). One of the most currently widely spread 
design philosophies is the user-centered design (Zaphiris, 2009) that makes users the 
most important element of design process. Wickens and co-authors (Wickens, 2004) 
have developed a list of principles for display design that take into account human’s 
limitations. These principles are subdivided into 4 categories: perceptual principles, 
mental model principles, principles based on attention and memory principles. For 
example, one of the memory principles is the principle of consistency: new 
information is easier to understand if it is designed in a consistent manner from one 
display to another.  
In the current research the principle of consistency of representation was used in 
providing translation mechanism between levels in the Network Representation 
Framework. According to our approach, moving between different levels of details 
the user stays within a comfortable familiar environment. That was possible due to 
using the same set of objects at all levels. Only small amount of new information is 
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added when moving to a more detailed level as described in Sections 4.3 and 5.2. 
Another application of this principle is used in the design of enzyme function 
representation: ‘functional gate’ entity represents enzyme function consistently on 
different types of diagrams  (see Section 6.5.3) and, in fact, provides consistent 
representation when events from different domains, such as metabolic and signalling 
pathways, have to be shown on a single diagram, for example for representing 
metabolism regulation (see Section 5.3). 
Progress of HCI research in the area of display design and information visualisation is 
necessary for further development of biological science and a number of researches 
and software developers address this concern (for example, Kang, 2008, Lee, 2006; 
Lieberman, 2011; Keefe, 2010; Perer, 2009; Plaisant, 2008; Shneiderman, 2006; also 
see Section 2.6 on the Edinburgh Pathway Editor).  
In this work we proposed to use a combination of existing paradigms together with 
the newly developed ones and test these on large real-life networks. Additionally we 
have performed a comparison of the usability of the new techniques and paradigms 
against the existing ones in a survey (Chapter 6). We hope that the outcomes of the 
current research would allow to design a better biological network representation 
system. 
 
The next section discusses existing approaches in systems biology in relation to 
biological network visulisation. 
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1.2 Network visualisation in systems 
biology 
According to Kitano (2002) the life cycle of systems biology research comprises the 
following stages: identification of a problematic fact, development of formalised 
research model, formulation of a hypothesis, simulation and analysis of the model, 
experimental design, experimental validation and data analysis and identification of a 
next iteration target. 
As highlighted in the survey done by Klipp et al. (2007), visualisation and drawing 
techniques have always been considered as part of the dissemination process rather 
than the development process. At the same time, in such a cross-disciplinary area as 
systems biology, the dissemination process becomes an essential part of the research 
life cycle. It is worth noting that all the steps above are conducted by the same team of 
researchers or become a part of the same project. Nevertheless, all six steps of the 
research should have an overarching goal thus and inform/be informed by knowledge 
generated both experimentally and computationally at each stage of the research. For 
the most part in systems biology experimentally oriented groups embark on stage one, 
three and five, while theoretical groups perform steps one, two, three and five. Let us 
consider what types of diagrams representing different types of knowledge are 
required at different stages of the development process. 
At the beginning of the modelling stage (Stage 2), reserachers identify the biological 
scope of a problem to solve, therefore define a context for further model development. 
Here ‘at a glance’ or ‘bird's eye’ types of diagrams are typically used. A good 
example of the ‘at a glance’ diagram is the PI3K/Akt Signalling pathway 
(http://www.cellsignal.com/pathways/akt-signalling.jsp) provided by CellSignal 
(CellSignal, http://www.cellsignal.com).  
Further development at this stage requires more detailed information about what is 
known and what are the ‘known unknowns’ about the system. Pathways collections 
from Biocarta (BIOCARTA: Charting pathways of life, http://www.biocarta.com), 
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ProteinLounge (ProteinLounge, http://www.proteinlounge.com), KEGG (Kanehisa et 
al., 2002), BioCyc (Karp et al., 2005), Edinburgh Human reconstruction (Ma et al., 
2007) and diagrams in MIM (Molecular Interaction Maps) (Kohn, 2001; Kohn and 
Aladjem, 2006), CellDesigner (Kitano et al., 2005), or Cytoscape (Shannon et al., 
2003) and other drawing tools are used for this purpose. The recently proposed SBGN 
(Systems Biology Graphical Notation, www.sbgn.org) notation is developing to 
standardize this type of diagrams. 
At the third step (Formulation of a hypothesis. Simulation and analysis of the model), 
the ‘known unknowns’ are replaced by the assumptions and biological hypothesis 
and, at this stage, some initial mathematical models can be formulated. The 
visualisation notations at this point can vary and depend upon the modelling platform. 
Models could be represented as SBML layout diagrams (Deckard et al., 2006; Gauges 
et al., 2006). Petri nets (Pinney et al., 2003) and LiveStateCharts (Kam et al., 2001) 
have their own visual notations. 
The choice of visual notation for the fifth step (Experimental validation and data 
analysis) generally depends upon the target audience. Usually it combines ‘model’ or 
‘pathway’ diagrams with charts, histograms, scatter plots from experimental data and 
results of data analysis.  
At the last step (Identification of a next iteration target) we will use ‘at a glance’ 
diagram again to visualise results and unresolved issues, and define a context for the 
next iteration of the research. 
To sum up, all described diagrams, used in a project life cycle, could be clustered into 
three main categories according to their purpose and the biological question under 
consideration:  
1. Outline and biological context visualisation. These help answering the 
question: What is the context or biological domain and scope for modelling?  
2. Existing experimental knowledge detailed representation. These help 
answering the question: What are the known facts?  
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3. Mathematical (in silico) model structure representation. These help answering 
the question: What is the detailed hypothesis for experimental computational 
check?  
Despite their importance, diagrams currently used in bioinformatics research are often 
ambiguous. On the one hand, the ‘at a glance’ diagrams, used at the steps one and five 
of the systems biology research cycle, by necessity are very ambiguous. This type of 
diagram requires textual description or explanation attached to it and should not be 
treated as an independent source of knowledge.  
On the other hand, the detailed diagrams usually do not contain enough evidence and 
references to experimental data for hypothesis formulation, and they should be 
upgraded by human annotators by providing references to original experiments and/or 
establishing casual relationships using intelligent guessing or assumptions. Ambiguity 
caused by missing knowledge or the lack of detailed information could be resolved by 
the ability to visually highlight such ‘grey areas’. In this case, strong evidence and 
corroborating data should be assigned to each element on the diagram. ‘Grey areas’ 
could be considered as target for modelling or experimental analysis. 
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1.3. Notations for unambiguous 
representation of cellular networks 
According to Hiroaki Kitano and co-authors ‘a successful diagram scheme must: (i) 
allow representation of diverse biological objects and interactions, (ii) be semantically 
and visually unambiguous, (iii) be able to incorporate notations, (iv) allow software 
tools to convert a graphically represented model into mathematical formulas for 
analysis and simulation, (v) have software support to draw the diagrams, and (vi) 
ensure that the community can freely use the notation scheme’ (Kitano et al., 2005). 
Currently three notations are discussed in detail: the Molecular Interaction Map 
(MIM) notation, the Process Diagram Notation and SBGN (Systems Biology 
Graphical Notation). 
Below we offer a brief overview and cross-comparison of each of these notations. 
The Molecular Interaction Map (MIM) notation. Kurt Kohn was the first to 
introduce a well-defined notation  that was able to visualise relationships between 
molecules in biological networks. To compare to the process diagram notation maps, 
the MIM diagrams differ in two ways: first, they ‘show each named molecular specie 
only once on a map’ and, second, ‘they do not specify particular event sequences, but 
instead show all of the interactions that can occur if potentially interacting species are 
in the same place at the same time’ (Kohn and Aladjem, 2006). 
The Process Diagram Notation (Kitano et al., 2005) is probably the most used 
today. Its main advantage is in allowing one to show cellular, metabolic and signalling 
events in an unambiguous way. Large examples have been prepared (Oda and Kitano, 
2006; Oda et al., 2005) and can be used as a source of knowledge about the biological 
system. Moreover, a special tool (CellDesigner: a modeling tool of biochemical 
networks, http://www.celldesigner.org/) is available for building diagrams in the 
Process Diagram Notation and storing them using the Systems Biology Markup 
Language (SBML).  
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On the basis of MIM notation and the Process Diagram Notation two languages of 
SBGN are being developed: Process Description (PD) language and Entity 
Relationships (ER) language (Systems Biology Graphical Notation, www.sbgn.org). 
Systems Biology Graphical Notation (SBGN). Systems Biology Graphical Notation 
project was initiated as a community effort by Kitano in 2005 (Kitano et al., 2005). 
Currently SBGN (Systems Biology Graphical Notation, www.sbgn.org) consists of 
three notations: Process Diagram (SBGN PD), Entity Relationship Diagram (SBGN 
ER), and Activity Flow Diagram (SBGN AF) (Le Novere et al., 2009). They aim to 
represent different slants of the same biological information. SBDG PD notation 
inherits many graphical elements and features of the process diagram notation. 
According to the original definition, this language describes ‘the causal sequences of 
molecular processes and their result’ (Systems Biology Graphical Notation: Process 
Diagram Level 1, www.sbgn.org, p.3). Entity Relationship language represents 
‘interactions between entities irrespective of sequence’ (Systems Biology Graphical 
Notation: Process Diagram Level 1, www.sbgn.org, p.3). Finally, the Activity Flow 
language is used to describe: ‘the flux of information going from one entity to another 
(Systems Biology Graphical Notation: Process Diagram Level 1, www.sbgn.org, p.3). 
While the first two languages in many ways correspond to the original Process 
Diagram Notation and the Molecular Interaction Map (MIM) notation, SBGN 
Activity Flow notation addresses the requirement to represent a network in a compact 
way showing only activity flow between entities. 
The symbols of the process diagram notation and the SBGN PD will be reviewed in 
more detail in sections 2.4 and 2.5. 
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1.4. Genome-scale metabolic network 
representation 
There have been many attempts to visualise genome-scale metabolic network as a 
wall chart or as a compact outline.  
The first example of wall chart diagrams were hand-drawn by Michal and called the 
Metabolic pathway wall charts (Michal, 1968). 
Another example is the IUBMB-Sigma-Nicholson Metabolic Pathways Chart 
(IUBMB-Nicholson: Metabolic Pathways Chart, http://www.iubmb-
nicholson.org/chart.html). The last version - the 22nd edition, 2003 - consists of about 
600 reactions that are identified by the IUBMB Enzyme Commission numbers (EC) 
(Deckard et al.). Although the chart contains only the ‘textbook’ pathways it provides 
a useful overview of metabolic pathways and can be successfully used for education 
purposes. On the other hand, as the chart is not linked to a constantly updated pathway 
database, that makes it less useful for complete network visualisation. Also the 
readability of such large maps is questionable - even with such a limited number of 
reactions it is difficult sometimes to follow links from one compound to another when 
they are far from each other on the chart. 
One more example of the wall chart diagrams is the Roche Applied Science 
‘Biochemical Pathways’ wall chart (Access to the digitized version of the Roche 
Applied Science ‘Biochemical Pathways’ wall chart via ExPASy, 
http://www.expasy.ch/cgi-bin/show_thumbnails.pl). Despite the obvious usefulness of 
such diagrams the questions remain: How easy it is to read the diagram? How easily 
can the diagram be updated? Can the compromise between a space limit and the 
necessity to show a great number of biological events be avoided? 
Comparatively small ‘at a glance’ diagrams present an overview of a metabolic 
network. Often the same scheme is reused when placing a particular phenomenon in 
the focus. 
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Simplified diagrams appear to be also useful for a network overview. For instance, a 
colourful map uploaded to Wikipedia (Wikipedia: Metabolic pathway, 
http://en.wikipedia.org/wiki/Metabolic_pathway) represents metabolic network as key 
metabolites and links between them. A coloured background shows major parts of a 
metabolic network or a particular metabolic pathway, for example the ‘Fatty acid 
metabolism’, ‘Amino sugar metabolism’ or ‘Urea cycle’. 
Recently, KEGG database introduced the KEGG Atlas (Okuda et al., 2008). The 
KEGG Atlas (KEGG Atlas, www.genome.jp/kegg/atlas/) has been developed as a 
graphical interface to the KEGG pathways. KEGG metabolism map 
(www.genome.jp/kegg/atlas/metabolism/2/) by manually combining 120 metabolic 
pathway maps. It is available online and is proposed to be used as a reference map to 
detailed KEGG pathways. In the KEGG metabolism maps, each node (circle) is a 
chemical compound identified by the C number. Each line (curved or straight) 
connecting two nodes is manually defined as a segment lacking branches in the 
existing maps, named NetElement, and identified by the N number. Each NetElement 
corresponds to one to several KO's in the reference pathway view, or one to several 
KO's in the reference pathway view, or one to several genes in an organism-specific 
view. Different parts of a metabolic network are shown in a different colour, key 
compound are shown as nodes and detailed map names are shown in corresponding 
places. Although compound names are not shown the main structure of the network is 
shown by nodes and lines. 
Other network visualisation projects have applied the concept of hierarchical levels of 
detail. The Reactome project (Reactome, http://www.reactome.org; Joshi-Tope et al, 
2005) offers interactive maps for navigation through their pathways, which include 
metabolic, signalling and gene expression pathways. Detailed pathways at different 
levels of detail share a simple common visual notation but use text descriptions to add 
semantic detail. 
Our experience in representing metabolic networks can be summarized as follows: 1) 
successful diagrams are manually prepared, 2) small diagrams are easier to read, 3) 
despite their size, large wall charts are not able to include all cellular events, 4) 
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interactive diagrams can be used for navigation through a metabolic pathway 
database. 
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1.5. Semantic zooming approach 
In order to deal with the huge amount of biological data, new technologies have to be 
considered for systems biology studies. Taking into account that detailed biological 
diagrams can be compared to geographical maps, the approach used in such popular 
software as Google Earth (Google Earth, http://earth.google.com), for example, might 
be taken as prototype for biological networks visualisation. 
Semantic zooming is being discussed as a perspective approach for graphical data 
representation in systems biology (Hu et al., 2007). It is important that in addition to 
scale enlargement semantic zooming also introduces new properties. Although objects 
remain the same, their number and their description can differ from layer to layer 
depending on context and the system of representation. 
An example of such expansion of a network while zooming is found in the work on 
the KEGG database hierarchy. Hu and co-authors has detailed the metabolic network 
on four levels (Hu et al., 2007). Metabolism is represented by 1 module on the first 
level. Then it is branched into 8 modules on the second level. The third level consists 
of 161 modules and fourth level contains 810 elements. 
The summary of the advantages of the semantic zooming are: 1) semantic zooming 
handles any large network as soon as objects in it are connected; 2) the data structure 
dictates how the hierarchy in each case must be developed; 3) if detailed diagrams are 
stored using an unambiguous notation, the semantic zooming approach can be used to 






The Unified Notation 
 
2.1. Introduction to the Unified Notation 
The Unified Notation (UN) has been developed for representing cellular pathway 
diagrams. It incorporates the most advantageous features of existing notations. 
Similarly to KEGG representation (KEGG, www.genome.jp/kegg), rather than using 
‘label inside a shape’ visualisation, ‘label near the symbol’ is used in the UN. This 
type of representation is based on the assumption that it will make the diagrams more 
compact and easy to understand. In the UN, signalling networks are represented as a 
set of reactions/state transitions and activation/inhibition links from 
activators/inhibitors to corresponding processes, similarly to the process diagram 
notation (Kitano et al., 2005). Symbols for Compound, Monomer, Homodimer, 
Heterodimer and Complex were adopted from GenNet maps (Ananko et al., 2002). 
Logic Gates and the concept of Multistate Protein/Complex representations were 
derived from the Edinburgh Pathway Notation (EPN) (Moodie et al., 2006). 
Furthermore, to address some shortcomings of the existing notations, three new 
symbols - the multistate entity, the identity gate and the functional gate - are added. 







2.2. System of symbols for unambiguous 
representation of cellular networks 
By entity here we understand any element/symbol of the notation that can be singled 
out from other elements/symbols on a diagram. 
2.2.1. Unknown/proposed entity (Table 2.1, A) symbol is used when an entity 
structure is unknown. It is represented by a rounded rectangle. For instance, a Toll-
like receptor ligand can be a compound or a protein and it can be shown as a generic 
entity with unspecified structure. 
2.2.2. Compound (Table 2.1, B) is an entity identical to the ‘simple molecule’ in the 
process diagram notation (Kitano et al., 2005) and is represented by a square box. 
2.2.3. Monomer (Table 2.1, C) is an entity identical to the ‘protein’ in the process 
diagram notation (Kitano et al., 2005) and is represented by an ellipse. 
2.2.4. Complex in the UN can be shown as Heterodimer (Table 2.1, E), Homodimer 
(Table 2.1, D) and Complex (Table 2.1, F). A heterodimer is represented by an ellipse 
and a circle. A homodimer is represented by two ellipses. A complex is represented 
by three circles. Complex is used if there are more than two macromolecules 
involved. A Complex composition is expressed in the complex name. Each element is 
shown on its own line in a list near the symbol. Multimers are shown as (PROTEIN 
NAME) n where n is cardinality. A complex state is shown near the symbol as a list 
of states of its component entities. The symbols for Heterodimer, Homodimer and 
Complex have been adopted from GenNet maps (Ananko et al., 2002). 
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2.2.5. Gene (Table 2.1, G) - any DNA species are represented by a rectangle. A type 
of DNA species can be specified inside a rectangle or in an entity name. 
2.2.6. RNA (Table 2.1, H) - any RNA species including mRNA, tRNA, miRNA etc. 
A type of RNA species can be specified inside RNA shape. 
2.2.7. State (Table 2.1, I) of an entity is shown as a label near a corresponding 
symbol. As in the process diagram notation (Kitano et al., 2005) the symbol ‘@’ is 
used to separate a modifier from a modified site. State naming rules for a monomer 
and complex are described in Table 2.2. If detailed information is not available, the 
state can be described in general way, for example: ‘unknown state’, or ‘active’. 
Unmodified states remain unlabelled. 
2.2.8. Multistate entity (Table 2.1, J). Anatoly Sorokin (personal communication, 
2007) suggested including all states of the same species into a special container to 
make the diagram easier to read. As a result, the multistate entity unites several states 
of the same specie into one container, thus saving space given that the name of the 
species is shown only once as a name of container ‘multistate entity’. 
2.2.9. Process (Table 2.1, K) entity includes reaction, association, dissociation and 
state transition, represented by a small circle. If these are identified processes, the 
Process symbol is in black colour. A circle remains uncoloured for proposed 
processes. This entity has at least two connectors: input and output. 
2.2.10. Translocation (Table 2.1, L) symbol shows the transport of species between 
different compartments, and is represented by a circle with the letter ‘T’ inside. This 
entity has at least two connectors: input and output. 
2.2.11. Gene expression (Table 2.1, M) symbol depicts translation of genetic 
information from DNA to RNA and from RNA to protein, and is represented by a 
small square. On a diagram this symbol has to be at least twice as small as a square 
box used for representing a compound so the two symbols could be distinguished 
easily. 
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2.2.12. Omitted processes (Table 2.1, N) symbol is used to mark hidden known or 
unknown steps. Similarly to the process diagram notation, the entity is represented by 
two lines. 
2.2.13. Unknown/proposed process (Table 2.1, O) symbol is used in cases where the 
evidence for a process is unconfirmed, and is represented by a circle with a question 
mark inside it. 
2.2.14. Activation (Table 2.1, P) link shows the stimulating influence of an entity on 
a process. It links the entity to the ‘process’ symbol. Represented by a link from an 
activator (protein or complex) to corresponding ‘process’ symbol with an arrow at the 
end (via a logic gate if more than one protein/complex involved). 
2.2.15. Functional gate (catalysis) (Table 2.1, Q) was initially introduced to keep the 
KEGG-like appearance of metabolic maps where EC numbers are usually shown. It 
also marks out catalysis and clarifies the function of the enzymes both in metabolic 
and signalling networks. The functional gate is represented by a rectangle with EC or 
TC number inside it. In case of a metabolic pathway the functional gate is not visually 
connected to any entity but is positioned near a corresponding ‘process’ symbol. If 
particular proteins/complexes with such enzyme activity are on a diagram, they are 
connected to the process via the functional gate. 
2.2.16. Inhibition (Table 2.1, R) shows negative influence on a process and connects 
an entity to the ‘process’ symbol. The inhibition is represented by a link from an 
activator (protein or complex) to a corresponding ‘process’ symbol with a bar at the 
end (via a logic gate if more than one protein/complex involved). 
2.2.17. Logic gates (Table 2.1, S) originate from the Edinburgh Pathway Notation 
(EPN) (Moodie et al., 2006). AND gate (Table 2.1, S) is used when all of the entities 
are required to affect a process. OR gate (Table 2.1, T) is used when any of the 
entities linked to the OR gate can affect a process. NOT gate (Table 2.1, U) is used 
when absence of an entity is required for activation/inhibition of a process. The AND 
logic gate is represented by a circle with the symbol ‘&’ inside it. The OR logic gate 
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is represented by a circle with ‘OR’ inside it. The NOT logic gate is represented by a 
circle with ‘NOT’ inside it. 
2.2.18. Identity gate (Table 2.1, V) is a newly introduced solution for visualisation of 
connection between generic and specific entities. The Identity gate is represented by a 
circle with the symbol ‘≡’ inside it. 
2.2.19. Compartment (Table 2.1, W) is a container that is used as a background for 
appropriate entities. 
2.2.20. Link (Table 2.1, X) marks connections to other maps. Represented by 
underlined text or by a circle with the ‘>‘ symbol inside it. 
2.2.21. Degradation (Table 2.1, Y) is an element that is used to show the removal of 
an entity when details of the degradation process are not important or unknown. 
2.2.22. Text (Table 2.1, Z) fields can be used for information that cannot be shown by 
using any of the other elements of the notation. 
 
The multistate entity (Table 2.1, J) is designed to reduce redundant diagram 
components in cases where successive state transitions alter a small number of the 
subunits of the complex only chemically. This results in the compaction of a diagram 
so that all states of the same proteins/complexes are located close to each other. 
Sections 2.4 and 2.5 give examples of the use of this symbol, compared to the SBGN 
Process Diagram notation (SBGN PD) (SBGN Process Diagram Level 1 specification, 
http://sbgn.org/Documents/Specifications) and to the process diagram notation (Oda 
and Kitano, 2006). 
 
The identity gate (Table 2.1, V) is a solution for the generic/specific compound 
problem. For example, quite often a subtype of a fatty acid, be it an amino acid, acyl-
CoA or D-glucose (which is alpha-D-glucose or/and beta-D-glucose), could be an 
appropriate reactant. However, there are occasions where the specific compound is 
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required. To make our network consistent we need to show that the generic compound 
‘amino acid’ is understood as a collection of all particular amino acids. In these cases, 
the ability to link generic and particular compounds (or a protein/complex in a 
particular state with the same protein/complex in unspecified state) via the Identity 
Gate is important, especially if both the generic and specific compound names are 
shown on the same map. Diagrams can be created to demonstrate parent-child 
relationships for a particular generic compound. Figure 2.1 shows such a diagram for 
a particular type of the generic compound, namely the ‘fatty acid’. The diagram 
displays the parent-child relationships between the generic compound ‘fatty acid’ (on 
the left), the intermediately specified compounds (in the middle), and the specific 
fatty acids (on the right). If a specific fatty acid is shown on the map of fatty acid 
biosynthesis, we should use the generic ‘fatty acid’ on another map in order to 
visualise the reaction of acyl-CoA formation (EC 2.3.1.85). 
 
The functional gate (Table 2.1, Q) is the way to use one of the most successful 
representations of metabolic pathways (KEGG metabolic diagrams) and, at the same 
time, be able to show signalling events on the same diagram without changing 
elements of metabolic pathway representation.  
Despite the fact that the EC number does not uniquely identify proteins/complexes 
involved, it is still very valuable information for a reader and is expressed in a concise 
way. Using EC makes it much easier to find a particular protein connected to the 
reaction.  
Here it should be said that EC on a signal transduction diagram is not that helpful as 
EC on a metabolic diagram, because the phosphorylation is the most common way to 
activate a protein, but not many ECs are connected to phosphorylation. Therefore, in 
case of signalling pathway it is reasonable to avoid using EC and names of the 
proteins can be used as identifiers instead. 
On the other hand, it is very common that a metabolic reaction is linked to many 
different proteins/complexes, and an attempt to show all of them on a diagram is most 
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likely to make it very difficult to read, as well as requiring a lot of additional 
unnecessary work.  
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Table 2.1. The Unified Notation's system of symbols. 
Symbol Entity Symbol Entity 




 L. Translocation 
 B. Compound  M. Gene expression 
 C. Monomer  N. Omitted processes 
 D. Homodimer  
O. Unknown/proposed 
process 
 P. Activation 
 E. Heterodimer 
 
Q. Functional gate 
(catalysis) 
 R. Inhibition 
 
F. Complex 
 S. AND gate 
 T. OR gate  
 
H. RNA 
 U. NOT gate 
 V. Identity gate 
 
J. State 
 W. Compartment 
LABEL  X. Link 
 Y. Degradation 
 
K. Multistate entity 
LABEL Z. Text 
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Table 2.2. State naming rules. 
State description Comments 
MONOMER STATE 
active General description is allowed if detailed information 
is not available 
MODIFIER @ SITE One site of a protein is modified 
MODIFIER 1 @ SITE1 
MODIFIER 2 @ SITE2 
... 
Several sites are modified simultaneously 
MODIFIER @ ? Site is unknown 
? @ SITE The type of modification is unknown 
n MODIFIER @ The same modification for several sites. Only for 
cases when it is not essential (or unknown) which 
sites are modified 
COMPLEX STATE 
PROTEIN1 MODIFIER1 @ SITE1 
PROTEIN2 MODIFIER2 @ SITE2 
... 
Complex state is described similarly to a monomer 





Figure 2.1. Fatty acid generic chart. 
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2.3. The UN grammar rules 
 
The UN has been developed as both a human-readable and a machine-readable 
graphical language so UN diagrams could be easily transformed into a model. For that 
all the entities must be linked properly. Tables 2.3 and 2.4 describe the connectivity 
rules in the UN. 
Table 2.5 summarizes the rules of containment for the ‘multistate entity’ and 
‘compartment’ entities.  
Labels on a diagram have to be presented in such way so it would be clear what object 
each label describes. In other words, a label should be positioned closer to the 
corresponding entity to exclude the possibility of any visual ambiguity. 
Similarly, entities consumed in a process have to be shown in such way so they would 
be visually clearly distinguished from entities produced as a result of that process. 
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Process input Source Source Source Source Source Source Source 
Process output Target Target Target Target Target Target Target 
Activation Source Source Source Source Source Source Source 
Inhibition Source Source Source Source Source Source Source 
Logical gate input Source Source Source Source Source Source Source 
Logical gate output NA NA NA NA NA NA NA 
Identity gate input Source Source Source Source Source Source Source 
Identity gate output NA NA NA NA NA NA NA 
Functional gate input Source Source Source Source Source Source Source 
Functional gate output NA NA NA NA NA NA NA 
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Target Target Target Target NA NA NA NA NA 
Process 
output 
Source Source Source Source NA NA NA NA NA 
Activation Target Target Target Target NA NA NA NA NA 
Inhibition Target Target Target Target NA NA NA NA NA 
Logical 
gate input 
NA NA NA NA Target Target Target NA NA 
Logical 
gate output 
Target Target Target Target Source Source Source NA NA 
Identity 
gate input 
NA NA NA NA NA NA NA Target NA 
Identity 
gate output 
NA NA NA NA NA NA NA Source NA 
Functional 
gate input 
NA NA NA NA NA NA NA NA Target 
Functional 
gate output 
Target Target Target Target NA NA NA NA Source 
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Table 2.5. Containers definition. 
 





 Unknown entity Possible Possible 
Compound Possible Possible 
Monomer Possible Possible 
Homodimer Possible Possible 
Heterodimer Possible Possible 
Complex Possible Possible 
Multistate entity NA Possible 
Compartment NA NA 
Process Possible Possible 
Unknown process Possible Possible 
Translocation NA Possible 
Omitted process Possible Possible 
Degradation NA Possible 
AND gate NA Possible 
OR gate NA Possible 
NOT gate NA Possible 
Functional gate NA Possible 
Identity gate NA Possible 
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2.4. Comparison between the UN and the 
SBGN 
 
The entities of the UN and the SBGN Process Diagram notation (SBGN PD) (SBGN 
Process Diagram Level 1 specification, http://sbgn.org/Documents/Specifications) are 
compared in detail in tables 2.6 - 2.10. Table 2.11 provides four examples of the 
notations.  
The main disadvantage of the SBGN in comparison with the UN is that it has been 
developed mainly for representing signal transduction networks and is less suitable 
for metabolic pathway visualisation. Two issues have to be mentioned here.  
First, the most useful metabolic pathway representations include EC numbers (KEGG 
database, for example). It is the most compact way to give information about the 
enzymes involved. In the SBGN the usual way to show EC is not available. In fact, it 
is possible to display a ‘protein’/’complex’ with a corresponding ‘unit of 
information’, but that would mean one is forced to annotate additionally all related 
enzymes. Another option would be to use an ‘unspecified entity’ with a corresponding 
‘unit of information’. In both cases the resulting diagram would be very cluttered.  
The second issue is the way SBGN shows labels inside of a shape. In the case of 
metabolic pathway labels, they would be shown partly outside of a ‘small molecule’ 
glyph, and the SBGN allows doing that as soon as a label is positioned in the center of 
a glyph. As compounds tend to have long names, sometimes comprising few lines, it 
makes difficult using horizontal links. In most cases instead of having straight line 
one needs to use several bend points for a link to avoid overlapping with a compound 
name. An alternative way would be to use larger shapes and smaller fonts so that a 
compound name would not appear outside of the ‘compound’ shape. In that case there 
are two options arise. The first option is to use different size for each ‘compound’ 
symbol fitting it in to a compound name. However that would not make a diagram 
look consistent. The second option is to use the same size for all ‘compound’ shapes 
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on a map, but that requires more space as the size of all ‘compound’ glyphs on a map 
depends on the longest compound name.  
However, the UN overcomes these difficulties using EC as a functional gate thus 
allowing positioning labels outside of the ‘compound’ symbol. 
Other significant differences between the two notations are listed below. 
1. The UN labels entity pool nodes by placing a label next to the symbol, while the 
SBGN places labels inside the shape. As a result, maps in UN notation are more 
compact. Although it could be suggested that a label area plus a shape area should be 
at least as big as a single shape with a text inside, the actual examples prove otherwise 
(Table 2.8, Figures 2.5 and 2.6). That is due to the fact that SBGN requires adding 
new shapes to display a protein state and that affects the size of a ‘macromolecule’ 
glyph significantly.  
2. ‘Complex’ entities are shown differently. The SBGN PD complex is shown as a 
container with particular entities inside it, whilst the UN uses a single symbol and lists 
entities involved near the symbol (Table 2.11, A). Positioning of elements in a 
complex container in the SBGN suggests certain structure of a complex that can not 
be fully described in this notation. Another difficulty could pose the cases where 
‘complex-in-complex’ visualisation is used because of several possible expressions 
available (Figure 2.2 A and B). In contrast, the UN shows the complex composition as 
a list of elements involved (Figure 2.2 C).  
3. While SBGN uses transition, association and dissociation as separate elements to 
show processes, UN uses a single symbol for all of them. At the same time, UN 
contains elements representing transport and gene transduction. The gene transduction 
(Table 2.8, D) is shown in UN by special symbols to avoid ambiguity, because it 
might be confused with a black box or child pathway. When appropriate visualisation 
is developed and information is available, translating information from gene to protein 
might be shown as a child pathway. 
4. UN introduces the multistate entity symbol (Table 2.11, B, C), a container that puts 
different states of the same protein/complex in one place. This serves several 
purposes. Firstly, it saves space by listing a complex composition only once as a name 
of a container. Secondly, it facilitates the placement of all states of an entity on a map. 
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Thirdly, it reduces the number of state combinations that have to be displayed, as it 
visually encapsulates all internal state transitions.  
5. UN introduces a new element - the ‘identity gate’ - to link generic and specific 
compounds. There are many cases when it is necessary to show generic and specific 
entities on the same map. For example, the Toll-Like Receptor(TLR) map (Oda and 
Kitano, 2006) shows connections between several particular ligands and generic 
compounds such as ‘TLR4 ligand’. 
6. Several connecting arcs that SBGN uses are not available in the UN, namely 
catalysis, modulation and trigger (absolute stimulation). Catalysis is represented in 
UN by functional gates (Figure 2.1, Q). Such elements as modulation and absolute 
stimulation are being considered for the next version of the UN. 
7. The UN notation has been designed to visualise both the signalling and metabolic 
pathways. ‘Compound’ symbol in UN is similar to the KEGG visual solution in 
metabolic pathway representation and seems to be more appropriate for showing 
entities that often have long names. Showing compound names inside an ellipse in 
SBGN PD takes more space. The UN proposes to keep the most efficient 
representation of a metabolic network by displaying labels outside of a shape, and 
also by using the ‘functional gates’ which appears as EC/TC on metabolic diagrams. 
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Table 2.6. Comparison between the UN and the SBGN. Entity pool nodes. 
Entity SBGN UN 
A. Unspecified entity  
 
B. Simple chemical   








G. Source/sink   
H. Perturbation  
Not available. Free text comments 
are used instead. 
I. Observable  
Not available. Free text comments 
are used instead. 
J. Tag  
No available. Direct link to 
another diagram is used instead 
K. Unit of information 
 
Not available. The entity type is 
shown by a symbol; complex 
composition is shown as a text. 
L. State variable 
  
M. Clone marker 
 
Not available. Even if it is 
necessary to show the same entity 
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several times on the same diagram 
no markers are used. All object 
have identifiers in EPE and 
similar entities are easily 
recognised. 
 36
Table 2.7. Comparison between the UN and the SBGN. Container nodes. 




B. Multistate entity 
Not available. Entities with the 
same name are not grouped in 








Table 2.8. Comparison between the UN and the SBGN. Process nodes. 
Entity SBGN UN 
A. Transition   
B. Uncertain process   
C. Omitted process   
D. Association  
 
E. Dissociation  
 
F. Translocation   




Table 2.9. Comparison between the UN and the SBGN. Connecting arcs.  
Entity SBGN UN 
A. Modulation  
Not available. Introducing in the 
next version of the UN is being 
discussed.  
B. Stimulation   
C. Catalysis (particular case of 
stimulation)  
Not available. Functional gates 
are used in case of catalysis 
D. Inhibition   
E. Trigger (absolute 
stimulation)  
Not available. Introducing in the 
next version of the UN is being 
discussed. 
F. Functional gate 
Not available. It is possible to 
show EC only as a name of a 
macromolecule (see chapter 9 for 
details). Introducing in the next 
version of the SBGN PD 
language is being discussed by 




Table 2.10. Comparison between the UN an the SBGN. Logical operators. 
Logical operator SBGN UN 
A. AND gate   
B. OR gate   
C. NOT gate   
D. Identity gate 
Not available. Introducing in the 
next version of the SBGN PD 
language is being discussed by 




Table 2.11. Comparison between the UN and the SBGN. Examples. 































Figure 2.2. Complex-in-complex case in the SBGN. Two possibilities to describe the 
resulting complex are available: A. SOS and Grb2 are shown as single proteins in the 
complex; B. SOS and Grb2 are shown as a complex-in-complex; C. The same events 
in the UN. 
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2.5. Comparison between the UN and the 
process diagram notation 
 
In order to demonstrate the advantages of using the UN and compare it to the process 
diagram notation, ‘a comprehensive map of Toll-like receptor signalling’ (Oda and 
Kitano, 2006) (Figure 2.3) has been transformed into a UN notation map (Figure 2.4). 
Without going into comparing the two notations symbol by symbol as it is done with 
SBGN PD notation, let us identify the most noticeable differences using examples 
from the Toll-receptor map in the process diagram notations and in the UN. 
First of all, taking into account the smallest font size, the UN has been proved to be 
more compact than the process diagram notation. The Toll-like receptor signalling 
map (Oda and Kitano, 2006) converted into the current version of the Unified 
Notation is at least twice as compact as the original map shown in the process 
diagram notation. This is mainly due to using the ‘label near a shape’ instead of the 
‘label in a shape’ visualisation (Figure 2.5). Also using the ‘multistate entity’ helps to 
minimize space for several states of the same protein complex (Figure 2.6). Figure 2.7 
shows another example of a complex representation. Figure 2.8 demonstrates the use 
of the ‘identity gate’ symbol in the UN. Figure 2.9 includes both versions of the same 








Figure 2.4. TLR signalling map (Figure 2.3) represented in the Unified Notation. 








Figure 2.5. ‘Name in the shape’ to compare to ‘name near the shape’. A. Raf1-
MKK1-KSR1 complex in the process diagram notation. B. Raf1-MKK1-KSR1 








Figure 2.6. Comparison of the same events shown in the UN and in the process 
diagram notation. A. A part of the toll-like receptor network diagram (Oda and 
Kitano, 2006). B. The same events shown in the UN. Names of the proteins in the 
complex are shown only once. The state in each case is shown near the symbol. 










Figure 2.7. A complex representation. A. In the process diagram notation. B. In the 








Figure 2.8. Using identity gates in the UN. The same detail from Toll-like receptor 






Figure 2.9. Readability and compactness. The same detail from Toll-like receptor 
signalling map is shown in the process diagram notation (A) and in UN (B). The same 
number of objects can be seen on both fragments. The font size is larger on the 
diagram in UN. 
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2.6. The Edinburgh Pathway Editor (EPE) 
and the UN implementation in EPE. 
This section briefly describes the Edinburgh Pathway Editor features relevant to the 
research, explains why the editor was chosen, and provides context definition (EPE 
concept of ‘context’ is introduced below) for the Unified Notation. 
The Edinburgh Pathway Editor (EPE) (Sorokin, 2006) is a Java-based and therefore 
platform-independent software. It is distributed under the Eclipse open-source 
application platform license (Sorokin, 2006). 
The editor uses a set of basic objects: shapes, processes, links and labels. These 
objects illustrate concepts of a biological network. Shapes represent biological objects 
such as compounds, macromolecules, complexes and subsystems. Processes show a 
sequence of events and allow a user to describe reaction, state transition etc. Links are 
reserved to show any relationships between two objects: shape-shape, shape-process 
and process-process. The levels represent textual information and hyperlinks to other 
maps or external resources (Sorokin, 2006). 
The information about maps is stored in the editor in a relational format. The Apache 
Derby database is supported by the tool and is used as local data storage (Sorokin, 
2006). 
The most important EPE feature for the current research is a concept of ‘context’. A 
‘context’ in EPE is a user-defined set of objects, their properties and default values 
that form a drawing palette for using a particular graphical language (Sorokin, 2006).  
The EPE allows creating hyperlinks and provides environment for developing 
hierarchical representation (Sorokin, 2006). 
Other pathway editors are currently available: CellDesigner (CellDesigner: A 
Modeling Tool of Biochemical Networks, http://celldesigner.org/), TERANODE 
(Design Automation for Life Sciences, http://www.teranode.com/), Bio Sketch Pad 
(Bio Sketch Pad, http://www.cis.upenn.edu/biocomp/new_html/biosketch.php3), 
Systems Biology Workbench JDesigner (SBW, http://www.sys-bio.org/), BioUML 
(BioUML Framework for Systems Biology, http://www.biouml.org/), BioTapestry 
(BioTapestry, http://labs.systemsbiology.net/bolouri/software/BioTapestry/), Pathway 
Builder (Pathway Builder Tool, http://www.proteinlounge.com/pathwaybuilder.asp), 
NetBuilder (NetBuilder Home, http://strc.herts.ac.uk/bio/maria/NetBuilder/), 
PathwayLab (PathwayLab, http://innetics.com/pathwaylab_overview.htm), VitaPad 
(Holford, 2005), PATIKA (Demir, 2002) and PathwayStudio (PathwayStudio, 
http://www.ariadnegenomics.com/products/pscentral/). Detailed comparison of the 
listed above applications and the EPE is provided by Sorokin and coauthors (Sorokin, 
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2006). The most distinctive advantage of the EPE is the combination of the following 
features: ability to represent networks of different types (metabolic, signalling, gene 
expression); possibility to add annotations; possibility to change visual and annotation 
properties; availability of import end export in SBML format; possibility to represent 
hierarchy of diagrams (Sorokin, 2006). 
The main reasons why the Edinburgh Pathway Editor was chosen rather than one of 
the listed above pathway editors:  
1) the EPE is highly flexibile in allowing to create, edit and annotate objects, which is 
essential for developing a new graphical notation; 
2) the editor supports definition of syntax and semantics of user-defined 
notation/context; and, finally; 
3) the possibility to work in close collaboration with the software developers’ team. 
The latter was possible because the group of the EPE software developers was part of 
the same Computational Systems Biology group I have been doing my research in and 
therefore new functionalities could be introduced when required for this research.  
 
The Unified Notation is defined in the Edinburgh Pathway Editor in the context 
‘Biological’. The list of the context objects (shapes, processes, labels and connectors) 
defined is provided bellow. 
 
2.6.1. MAP 
Map name: <TEXT> 
Grid: On 
Grid Size. Height: 32.  
Grid Size. Width: 32 
Corresponding EMP map ID(s): <SIMPLE DATA> 
Corresponding KEGG map ID(s): <SIMPLE DATA> 
Organism: <TEXT> 
Tissue/cell type: <TEXT> 
Last updated: <DD.MM.YYYY> 
 
2.6.2. SHAPES 
2.6.2.1. Unknown entity 
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Shape: Rounded rectangle 
Fit to text: Off 
Size: Height: 30. Width: 30 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 92, 99, 143 
Line style: solid 
Line width: 1 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Name: <TEXT> 
Synonyms: < TEXT COLLECTIONS> 
UniProt ID: <TEXT> 





Entity ID: <SIMPLE DATA> 
KEGG compound ID: <SIMPLE DATA> 
EMP compound ID: <SIMPLE DATA> 
Shape: Rectangle 
Fit to text: Off 
Size: Height: 16. Width: 16 
Background colour: RBG 157, 159, 189 
Foreground colour: RBG 92, 99, 143 
Line style: solid 
Line width: 2 
Name: <TEXT> 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Synonyms: < TEXT COLLECTIONS> 
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Fixed: <Yes / No> 
Hyperlink: <TEXT> 
 
2.6.2.3. Protein  
UniProt ID: <TEXT> 
Shape: Ellipse 
Fit to text: Off 
Size: Height: 20. Width: 24 
Background colour: RBG 157, 159, 189 
Foreground colour: RBG 92, 99, 143 
Line style: solid 
Line width: 1 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Name: <TEXT> 
Synonyms: < TEXT COLLECTIONS> 
Protein state: <TEXT COLLECTION> 
State: $protein state@\n$ 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
 
2.6.2.3. Homodimer  
Shape: Homo dimer 
Fit to text: Off 
Size: Height: 25. Width: 35 
Background colour: RBG 157, 159, 189 
Foreground colour: RBG 92, 99, 143 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
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Protein name: <TEXT > 
Name: ($protein name$)2 
Synonyms: <EXT COLLECTIONS> 
Complex state: <TEXT COLLECTION> 
State: $protein state@\n$ 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
 
2.6.2.4. Heterodimer  
Shape: Hetero dimer 
Fit to text: Off 
Size: Height: 25. Width: 35 
Background colour: RBG 157, 159, 189 
Foreground colour: RBG 92, 99, 143 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Complex composition: <TEXT COLLECTION > 
Name: $complex composition@\n$ 
Synonyms: <TEXT COLLECTIONS> 
Complex state: <TEXT COLLECTION> 
State: $protein state@\n$ 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
 
2.6.2.5. COMPLEX  
Shape: Complex 
Fit to text: Off 
Size: Height: 30. Width: 31 
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Background colour: RBG 157, 159, 189 
Foreground colour: RBG 92, 99, 143 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Complex composition: <TEXT COLLECTION > 
Name: $complex composition@\n$ 
Synonyms: <TEXT COLLECTIONS> 
Complex state: <TEXT COLLECTION> 
State: $protein state@\n$ 




Gene ID: <SIMPLE DATA> 
Shape: Rectangle 
Fit to text: Off 
Size: Height: 16. Width: 40 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 2 
Name: <TEXT> 






Fit to text: Off 
Size: Height: 16. Width: 40 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Name: <TEXT> 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
 
2.6.2.8 Multistate entity 
Shape: Rounded rectangle 
Fit to text: Off 
Size: Height: 80. Width: 80 
Background colour: RBG 242, 242, 247 
Foreground colour: RBG 128, 128, 128 
Snap options. Snap location: On. Snap size: On. Snap Type: Edge 
Line style: solid 
Line width: 1 
Name: <TEXT> 






Fit to text: Off 
Size: Height: 21. Width: 21 
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Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Name: <TEXT> 





Fit to text: Off 
Size: Height: 64. Width: 64 
Background colour: RBG 237, 237, 220 
Foreground colour: RBG 147, 146, 98 
Snap options. Snap location: On. Snap size: On. Snap Type: Edge 
Line style: solid 
Line width: 1 
Name: <TEXT> 





Fit to text: Off 
Size: Height: 32. Width: 64 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 255, 255, 255 
Snap options. Snap location: On. Snap size: On. Snap Type: Edge 
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Line style: solid 
Line width: 1 
Name: <TEXT> 





2.6.2.12. Link to another map 
Shape: Rounded rectangle 
Fit to text: Off 
Size: Height: 64. Width: 128 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Edge 
Line style: solid 
Line width: 1 
Name: <TEXT> 





2.6.2.13. Map name 
Shape: Rectangle 
Fit to text: On 
Size: Height: 72. Width: 720 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 255, 255, 255 
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Snap options. Snap location: On. Snap size: On. Snap Type: Edge 
Line style: solid 
Line width: 1 
Name: <TEXT> 




Text colour: RGB 128,128,128 
 
2.6.3. LABELS 
2.6.3.1. Name label 
Shape: Rectangle 
Fit to text: On 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 255, 255, 255 
Line style: solid 
Line width: 0 
Label position: Top-right 
Text: $leader.name$ 
Font size: 14 
 
2.6.3.2. State label 
Shape: Rectangle 
Fit to text: On 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 255, 255, 255 
Line style: solid 
Line width: 0 
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Label position: Top-right 
Text: $leader.state$ 





Fit to text: Off 
Size: Height: 7. Width: 7 
Background colour: RBG 0, 0, 0 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reaction ID: (SIMPE COLLECTION) 
KEGG reaction ID: (SIMPE COLLECTION) 
Reaction equation: (TEXT COLLECTION) 
Reversible: (SIMPE COLLECTION) 
EC: (SIMPE COLLECTION) 




Fit to text: Off 
Size: Height: 17. Width: 17 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
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Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Text: T 
Reaction ID: (SIMPE COLLECTION) 
KEGG reaction ID: (SIMPE COLLECTION) 
Reaction equation: (TEXT COLLECTION) 
Reversible: (SIMPE COLLECTION) 
EC/TC: (SIMPE COLLECTION) 
Subpathway: (TEXT COLLECTION) 
 
2.6.4.3. Gene expression 
Shape: Rectangle 
Fit to text: Off 
Size: Height: 11. Width: 11 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 2 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reversible: (SIMPE COLLECTION) 
Subpathway: (TEXT COLLECTION) 
 
2.6.4.4. Omitted process 
Shape: Ellipse 
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Fit to text: Off 
Size: Height: 17. Width: 17 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reversible: (SIMPE COLLECTION) 
Subpathway: (TEXT COLLECTION) 
Text: // 
 
2.6.4.5. Unknown/proposed process 
Shape: Ellipse 
Fit to text: Off 
Size: Height: 17. Width: 17 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reversible: (SIMPE COLLECTION) 
Subpathway: (TEXT COLLECTION) 
Text: ? 
 
2.6.4.6. OR gate 
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Shape: Ellipse 
Fit to text: Off 
Size: Height: 19. Width: 19 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reversible: (SIMPE COLLECTION) 
Subpathway: (TEXT COLLECTION) 
Text: OR 
 
2.6.4.7. AND gate 
Shape: Ellipse 
Fit to text: Off 
Size: Height: 19. Width: 19 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reversible: (SIMPE COLLECTION) 




2.6.4.8. NOT gate 
Shape: Ellipse 
Fit to text: Off 
Size: Height: 19. Width: 19 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reversible: (SIMPE COLLECTION) 
Subpathway: (TEXT COLLECTION) 
Text: N 
 
2.6.4.9. Identity gate 
Shape: Ellipse 
Fit to text: Off 
Size: Height: 19. Width: 19 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reversible: (SIMPE COLLECTION) 




2.6.4.10. Functional gate 
EC: <SIMPLE DATA> 
Shape: Rectangle 
Fit to text: Off 
Size: Height: 24. Width: 300 
Background colour: RBG 255, 255, 255 
Foreground colour: RBG 0, 0, 0 
Snap options. Snap location: On. Snap size: On. Snap Type: Center 
Line style: solid 
Line width: 1 
Fixed: <Yes / No> 
Hyperlink: <TEXT> 
Reversible: (SIMPE COLLECTION) 




2.6.5.1. Process input 
Foreground colour: RGB 0, 0, 0 
Line style: solid 
Line width: 1 
Router: Manual 
Source decorator: None 
Target decorator: Triangle 
 
2.6.5.2. Process output 
Foreground colour: RGB 0, 0, 0 
Line style: solid 
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Line width: 1 
Router: Manual 
Source decorator: None 
Target decorator: None 
 
2.6.5.3. Activation 
Foreground colour: RGB 0, 0, 0 
Line style: solid 
Line width: 1 
Router: Manual 
Source decorator: None 
Target decorator: Arrow 
 
2.6.5.4. Inhibition 
Foreground colour: RGB 0, 0, 0 
Line style: solid 
Line width: 1 
Router: Manual 
Source decorator: None 
Target decorator: Bar 
 
2.6.5.5. Gate input 
Foreground colour: RGB 0, 0, 0 
Line style: solid 
Line width: 1 
Router: Manual 
Source decorator: None 





The Network Representation 
Framework 
 
3.1. Introduction to the Network 
Representation Framework 
The previous chapter described the system of symbols that allows one to show 
signalling and metabolic events unambiguously.  
Nevertheless, the system does not resolve all the difficulties in biological network 
visualisation. Even if individual phenomena can be shown comprehensively, the 
problem of representing large biological networks still remains. Although some 
approaches look promising (Sections1.4 and 1.5), so far there has been no effective 
system introduced and exemplified for that task. 
The Network Representation introduced in this thesis uses a system of rules that 
allows us representing genome-scale networks successfully, and review them on 
different levels of detail (Sorokin A, personal communication, 2006). This system is 
based on the use of comparatively small and detailed maps that are used as bricks for 
developing large networks. The system based on these maps has the following 
properties: 1) three categories of maps are used in order to view a biological system 
from different perspectives (detailed below); 2) the maps are organised hierarchically; 
 68
3) this hierarchic structure is used not only for visualisation of a network, but also 
provides the means for assembling individual detailed maps into larger virtual maps. 
 
3.2. Organization of pathway diagrams 
It could be quite challenging to put everything on to a single, all-encompassing map. 
The larger the diagram, the greater the difficulty in reading and making changes to it; 
moreover, it makes the task of updating the diagram very difficult. 
One can compare creating pathway diagrams with organizing words in sentences 
while writing a book. There are many words, but their number is limited. Similarly, 
the number of cellular processes in biology is limited as well. By arranging these 
elementary processes in to a structured whole, we are creating pathway maps that 
have the following properties. First, a map has to be meaningful. Second, a size of 
map should not be too large or too small.  
During our research on human metabolic pathways and the macrophage signalling 
network it has been estimated that the most convenient number of processes on a 
single diagram is about 40-80. That gives printer-friendly, readable, maintainable 
maps and provides a basis for the hierarchical organization of the diagrams. The 
characteristics of the different categories of diagrams are shown in Table 3.1. Several 
levels of diagrams can be shown if desired. 
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 3.3. Three categories of diagrams 
All the diagrams we use for visualisation and analysis of biological networks can be 
organised in to three categories (Table 3.1).  
PHENOMENOLOGICAL diagrams (or outlines) express our knowledge about a 
system at different levels of abstraction, or underline some particular aspect. 
BIOLOGICAL diagrams show all known facts unambiguously. A well-defined 
notation is very important here.  
KINETIC diagrams are created on the basis of biological diagrams and unknown facts 
are replaced by assumptions so the full kinetic mechanism could be represented. The 
kinetic model diagrams can be converted into SBML, ODE or other dynamic models 
for further simulation, analysis and hypothesis generation. 
Phenomenological category of diagrams: This category includes schematic 
representations of biological phenomena, for example an outline view that helps 
understanding of a network structure. Here knowledge representation requires 
additional textual description.  
In the Network Representation a phenomenological diagram is made semantically 
clear by being linked to appropriate biological diagrams. In this sense the key element 
on a phenomenological map is linked to sub-level diagrams. A link could be  a special 
symbol (such as the ‘link glyph, table 1X) or underlined text.  
Our example of metabolic network representation (Chapter 4) shows that it is 
convenient to develop several sub-levels inside the phenomenological layer. This 
could be done to unite related diagrams into a single network; furthermore, by using 
an outline of outlines it could be formed into an even larger network. This way 
phenomenological diagrams serve several purposes. Firstly, they provide an easily 
readable and navigable representation of biological phenomena. Secondly, 
phenomenological diagrams could be assembled into a single system or a virtual 
network environment. Finally, a separate phenomenological diagram can be used to 
reveal a particular aspect of a biological system, or to describe a large kinetic model 
without all unnecessary details. 
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Biological category is an unambiguous representation of an experiment-based 
knowledge. Corresponding references to the papers with experimental evidence must 
be provided. All related facts have to be shown in a well-defined notation in a format 
that is both human and machine readable. The United Notation is used for that in the 
Network Representation, but other formal notations could be used as well, for 
example the process diagram notation or the SBGN PD notation.  
Kinetic category is an exact kinetic model structure representation. Kinetic category 
diagrams use the same visual elements as the biological category diagrams. However, 
while both biological and kinetic diagrams show facts that are known, the latter also 
contain assumed/unconfirmed events, replacing unknown information with 
assumptions to make them directly convertible to SBML, or other mathematical 
representation. 
Depending on the size of a model, it could be connected to one or several biological 
diagrams. Similarly to a biological layer, the kinetic model can consist of many 
kinetic diagrams connected to each other. Again, an outline (or phenomenological 
diagram) can be used to assemble several kinetic diagrams into one virtual 
environment. 
Figures 3.2 - 3.4 demonstrate how the same events of EGFR signalling can be 
represented as phenomenological, biological and kinetic diagrams. A 
PHENOMENOLOGICAL diagram (Figure 3.2) in this example represents EGFR 
signalling as a network of protein-protein interactions. The corresponding 
BIOLOGICAL diagram (Figure 3.3) visualises detailed information based on 
experimental data from the literature. The KINETIC diagram (Figure 3.4) of the 
EGFR signalling by Kholodenko et al. ( 1999) does not repeat biological diagrams as 
several assumptions are added and resuling kinetic model is shown. 
Taken together, the collection of these categories is defined as the Network 
Representation framework (NR). 
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Figure 3.2. Early events of EGFR signalling. PHENOMENOLOGICAL MODEL.  An 
outline for the detailed EGFR signalling map (Figure 3.3) represents the events as 
protein-protein interactions. Each link from these diagrams corresponds to a more 
complex and detailed representation on biological layer. On this diagram a link to 
another diagram is represented by circled symbol ‘>‘. Each macromolecule from the 
phenomenological layer corresponds to the same entity or corresponding entity 





Figure 3.3. Early events of EGFR signalling. BIOLOGICAL MODEL. Events on a 
biological diagram has to be represented in a well-defined notation. In this case it is 
done in the UN, but using other graphical language is possible too. For example, 
including SBGN PD language as an alternative to the UN in the Edinburgh Pathway 
Editor is discussed. 
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Figure 3.4. Early events of EGFR signalling. KINETIC MODEL by Kholodenko 
(Kholodenko et al., 1999) represented in the NR. Each macromolecule from the 
kinetic diagram corresponds to the same or similar (due to possible differences in 
complex representation on these two layers) entity on the biological level (Figure 3.3). 
It is possible that the system is represented here with more details, less details or even 
both when some events are shown in more details and some are omitted. On this 
diagram the receptor complex is shown in more details to compare to the biological 
one. An example of simplified representation is the events that include Ras protein. 
Names could be modified if it helps to make a kinetic scheme easier to understand or 
simply because the names correspond to the name used in equations etc. Numbers 
used here correspond to the equation of this model (Kholodenko et al., 1999).  
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3.4. The hierarchically organized system 
of diagrams 
All three categories of diagrams are connected in the Network Representation 
framework. The connection is facilitated by three groups of links. 
1. Links from one biological diagram to another biological diagram via shared 
elements (for example, shared compounds, proteins or a set of events). 
2. Links from an outline (phenomenological model) to a set of detailed diagrams 
(biological model). A set of detailed diagrams via shared elements can be assembled 
into a single virtual map. For example, three biological diagrams of the EGFR 
signalling network (Figures 3.5 – 3.7) can be joined by an outline (Figure 3.8) into a 
single virtual map. This virtual map can be visualised if necessary (Figure 3.9). 
One biological diagram can be linked to many outlines and be included in multiple 
virtual maps. 
3. Kinetic diagrams are linked to a corresponding detailed map or to an outline (to a 
large virtual detailed map).  
The most important advantages of the system are: 
1) There is no need to draw large maps in order to describe a large system. As maps 
can be comparatively small, it is easy to review, check and update them. 
2) A single framework is able to visualise a large system if necessary, due to the 
hierarchical organization of different types of diagrams. Outlines can be created at as 
many levels of generalization as necessary. 
3) The diagrams that are created based on experimental data are clearly separated 
from biological and mathematical diagrams, i.e. those in which assumptions or 
proposed events are added.  
4) As the NR is adapted to using different languages (from a graphically ambiguous 
scheme to kinetic model visualisation), it can be used as a data-sharing and model-
sharing environment by both biologists and mathematicians. 
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In the Network Representation framework outlines play an essential role as they are 
used for network management. In reality, there exists no single metabolic or 
signalling network, given that different cell types display varying subsets of possible 
pathways at different developmental stages or in varying environmental conditions. 
The framework described here enables the construction of cell- and developmental 
stage-specific virtual maps. This is done by combining appropriate subsets of detailed 
maps. For example, for the liver-specific metabolic network steroid hormone 
metabolism is not going to be included. 
The next two chapters show how the framework can be used for visualising large 
networks. 
There are several ways to prepare outlines on phenomenological layer. Some of the 
possible ways to represent diagrams are listed bellow. 
1. A shape/box on an outline corresponds to a map on the lower level; 
2. A shape/box on an outline corresponds to a map fragment on the lower level; 
3. A connector on an outline could signify one or several events on the lower 
level (Figures 3.2); 
4. An object from an outline (for example, a macromolecule, a complex or a 
metabolite) could correspond to an object with the same name or several 
objects with the same name but different states (Figure 3.3). 
It is important to clarify that designing the way information from biological layer is 
presented on an outline, or information from lower level outline(s) is presented on a 
higher level outline, is a task that is more complex than simple linkage of diagrams 
from different levels. Diagrams from a lower level can be represented on an outline in 
a very straightforward way: any object (simple box) can be used as a link. The 
challenge is to show information in such a way that it could be used for better 
understanding of a network structure.  
This multi-level linkage approach was used in developing systems of outlines for the 
Edinburgh Human Metabolic Network (Chapter 4) and outlines of the TNF-alpha 
receptor signalling network (Chapter 5). The aim was to provide a better 
understanding of a network using simplified text-book-like representations where 
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each outline diagram refers to lower level diagrams and contains selected objects from 
those diagrams to provide consistency in representation. In other words, the same 
entity (macromolecule or metabolite) is presented on several outline/detailed levels, 
but represents more details.  Sections 4.3 and 5.2 describe the way a detailed diagram 
is ‘translated’ into an outline in further details. Additionally, it should be said that all 
the outlines have been created manually. However, the generation of this type of 














Figure 3.7. EGFR signalling network. BIOLOGICAL. RSK2-PDK1 signalling. 
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Figure 3.8. EGFR signalling network. PHENOMENOLOGICAL MODEL 
(OUTLINE). Similarly to the outline for EGFR pathway (Figure 3.2) the main 
macromolecules involved in the pathway are shown. The connectors represent 
protein-protein interaction shown as biochemical events on the detailed diagrams in 
the UN (Figures 3.5 – 3.7). The symbols (>) from the connectors lead to 




Figure 3.9. EGFR signalling network. BIOLOGICAL. Three diagrams united into a 
single map. This diagram shows resulting network that created based on the outline 
(Figure 3.8). Thee biological maps are united into a single map. Shared on primal 
diagrams elements are used to properly connect separate pathway into one. It is 






Metabolic network representation 
 
The Network Representation Framework (NRF) described in the previous chapter 
requires a large biological network to prove its abilities. This chapter introduces an 
extensive example of the NRF application. In the Network Representation Framework 
an extensive metabolic network is represented at several levels of granularity. 
Representing a network at several levels of granularity allows one to keep a network 
representation compact yet providing sufficient level of details. In our example, each 
diagram included fits within a reasonable printer-friendly size.  
Representation of the human metabolic network was developed in 2 steps that are 





4.1. Step 1. Visualisation of detailed 
metabolic pathways 
During our work on the Edinburgh human metabolic network that contains 
approximately 3000 reactions (Ma et al., 2007) I participated in preparing the dataset 
and was responsible for the pathways visual representation. The goal was to compare 
reactions from the two initial datasets from KEGG and EMPProject in order to avoid 
repetitions and exclude as many mistakes as possible. On the next stage of the project 
my responsibility was to subdivide the reactions into different pathways. For that the 
KEGG pathway has been compared to EMPProject pathways, all the reactions in the 
dataset have been subdivided into subpathways and a new set of pathways has been 
created bearing in mind a goal that one pathway should contain no more than 100 
reaction to have a printer-friendly size. All the pathways have been visualised in the 
UN using the Edinburgh Pathway Editor (Sorokin, 2006). Visualisation of the dataset 
has appeared to be important not only because it is easier to read a graphical 
representation rather than textual description, but also because in the process 
unconnected parts of the pathway have been discovered and then missing reactions 
have been added.  
The results of this work were published in 2007 (Ma et al., 2007). 
In order to make transformation from textual representation of the pathways (Excel 
file) to graphical diagrams in the UN, special EPE plugins have been developed by 
the Computational Systems Biology’s team of software developers that are working 
on EPE, particularly by Richard Adams and Shakir Ali. My role was to develop 
corresponding context in EPE (‘Metabolic’) and specify what data have to be 
uploaded to what field of the context. Next, automatic layout plugin has been 
prepared by Richard Adams. The initial idea for the plugin was to combine existing 
algorithms of graphical layouts and take into account the grid size of a map. That puts 




4.2. Step 2. Developing a system of 
outlines for human metabolic network 
representation 
 
Applying the NRF to the Edinburgh human metabolic network, a system of outlines 
has been developed to show networks at different levels of detail. This system of 
outlines has at least three important functions:  
1) providing navigation through the whole network;  
2) outlines (phenomenological diagrams) provide an intelligent overview;  
3) each outline unites lower-level diagrams into one large virtual map. 
While developing the outlines many different examples of metabolic network 
representation (Section 1.4) have been taken into account. The main idea of the 
proposed outline system was to provide a user with 1) useful text-book oriented 
version of the main outline where only the most known metabolites and pathways (for 
example, glycolysis) are represented and then 2) show more details on the next level 
where a set of outlines would be prepared and each of them would correspond to the 
major area of metabolism. Finally, 3) detailed metabolic diagrams in the UN could be 
made available through navigation via the two layers of the outlines described above. 
The result of this work is illustrated in Figures 4.1 – 4.14. 
The main outline provides an overview of the whole network and underlines the 
connection between major parts of the network (Figure 4.1). Links connect the main 
outline to eleven outlines of the lower level (Figures 4.2 – 4.12). The lower level 
outlines in their turn are linked to the detailed diagrams. 
Each major part of metabolism is represented by a separate outline and each of them 
is linked to the main outline (Figure 4.1): Carbohydrate metabolism, Amino acid 




metabolism, Glycerophospholipid metabolism, Steroid metabolism, Vitamins and 
Porphyrin metabolism (Figures 4.2 – 4.12). Links from each of the outlines on this 
level lead to another more detailed representation of metabolic pathway on a 
biological layer. Figure 4.13 shows one of such detailed diagrams. In the Edinburgh 
Pathway Editor (EPE) it is possible to navigate through the network using hyperlinks 
(Figure 4.14). The enclosed copy of the CD contains a portable version of EPE with 
pre-installed database that contains all the examples including the EHMN 
visualisation. 
The approach used for preparing the system of outlines is described in the next section 
as a proposed algorithm for semi-automatic outline generation so this work could be 





Figure 4.1. The EHMN outlines. Human metabolic network (main outline). Please use 





Figure 4.2. The EHMN outlines. Amino acid metabolism. Please use the CD provided 





Figure 4.3. The EHMN outlines. Nucleotide metabolism. Please use the CD provided 





Figure 4.4. The EHMN outlines. Carbohydrate metabolism. Please use the CD 





Figure 4.5. The EHMN outlines. Fatty acid biosynthesis. Please use the CD provided 





Figure 4.6. The EHMN outlines. Essential fatty acid metabolism. Please use the CD 





Figure 4.7. The EHMN outlines. Eicosanoid metabolism. Please use the CD provided 





Figure 4.8. The EHMN outlines. Sphingolipid metabolism. Please use the CD 





Figure 4.9. The EHMN outlines. Glycerophospholipid metabolism. Please use the CD 





Figure 4.10. The EHMN outlines. Steroid metabolism. Please use the CD provided to 










Figure 4.12. The EHMN outlines. Porphyrin metabolism. Please use the CD provided 










Figure 4.14 Navigation through the network. Navigation is possible due to hyperlinks 





4.3. Informal description of proposed 
method for semi-automatic outline 
generation: metabolic network. 
Before the algorithm is described, it is necessary to introduce the elements/symbols 
that are used on metabolic outlines. Then we can use this vocabulary in the algorithm 
description. 
The term ‘outline’ is used as a synonym of phenomenological model (Chapter 3). We 
use two levels of outlines: ‘lower level outlines’ (first, more detailed level of outlines) 
and ‘higher level outlines’ (second, less detailed level of outlines). Potentially more 
levels of abstraction could be added: third, fourth levels of outlines and so on. For the 
purpose of this example only two levels are used. The term ‘link’ refers to a hyperlink 
that connects one diagram (map) to another diagram. Links from the higher level 
outlines lead only to the lower level outlines. Links from the lower level outlines lead 
only to the detailed diagrams (‘biological diagram’ or ‘biological map’) that 
correspond to biological model (Chapter 3). The terms ‘editor’ or ‘tool’ refer to any 
editor that is able to support such functionalities as data import, automatic layout, 
semi-automatic outline generation. We consider the process of creating outlines being 
done in a semi-automatic fashion because a list of entities (in this case compounds) 
for each level of outlines has to be prepared partly via automatic analysis of a network 
and partly manually selected by an expect. 
Symbols that are used on a metabolic outline (please see Figures 4.1 and 4.10 for 
examples): 
A. ‘Compounds’ on an outline are the same entities that are used on biological 
diagrams. 
B. Connectors link two compounds and replace ‘process’ entity from biological map. 
C. In cases when two or more reactions on a biological diagram are represented by a 




outline. This way even on an outline it is clear if two compounds have one or 
more reaction between them. 
D. ‘Pathway container’ is a rectangular shape with a map name in it. ‘Pathway 
container’ is used as a hyperlink (‘link’). In theory any element on a map can be 
used as a hyperlink including compounds and connectors. In this example only 
‘pathway container’ element is used for that. The lower level of outlines shows 
compounds using ‘pathway container’ as a background. In that case each 
‘pathway container’ includes only the compound that belongs to the pathway that 
the ‘pathway container’ refers to. The higher level of outlines shows ‘pathway 
container’ near the metabolites that correspond to the pathway that this ‘pathway 
container’ refers to. 
The algorithm for outline generation description follows below. There are 3 main 
parts: biological pathways visualisation (steps 1-3), the lower level outlines 
visualisation (steps 4-6) and the higher level outlines visualisation (step 7). 
1. Biological pathway visualisation. Step 1. A set of reaction of a metabolic network 
has to be defined and stored in excel file, SBML file or any other format that could be 
imported by a tool that enables automatic layout.  
2. Biological pathway visualisation. Step 2. The reactions have to be subdivided into 
comparatively small pathways according to the part of metabolism they belong to. 
Existing reaction distribution in pathways can be used as an example, for example 
Kyoto Encyclopaedia of Genes and Genomes (KEGG, www.genome.jp/kegg) and the 
Edinburgh human metabolic network (Ma, 2007). The number of reaction in each 
pathway should not exceed approximately 100 reactions so the diagram could be kept 
at reasonable printer-friendly size. One reaction can be assigned to several metabolic 
pathways if necessary.  
3. Biological pathway visualisation. Step 3.The reaction in excel, SBML or any other 
appropriate format should be uploaded into an editor that enables automatic layout. 
The pathways has to be visualized and automatically/semi-automatically layed out. 
Alternatively, the pathways could be visualised manually. 




several groups according to the major area of metabolism they belong to. One 
pathway can be assigned to several groups if necessary. In other words, the reactions 
that have been assigned to the pathways (biological maps) and then to larger groups 
(correspond to the set of the lower level of outlines). The outlines on the lower level 
outlines correspond to these larger groups such as Carbohydrate metabolism, Amino 
acid metabolism, Fatty acid metabolism etc. 
5. The lower level of outlines. Step 2. A list of compounds that is going to be shown 
on the lower level outlines has to be prepared. The compounds that are proposed to be 
included in the lower level outlines:  
• inputs and outputs of the pathway;  
• ‘important’/textbook compounds (all the amino acids, all the fatty acids, all 
the glycolysis pathway compounds, vitamins etc);  
• compounds that are in cross-talk between several pathway ‘roads’; 
• compounds that appear on several pathways. 
6. The lower level of outlines. Step 3. Ideally, a special plugin should be used so the 
tool could import the list of compounds and using information on how the compounds 
are linked on the maps to automatically generate an outline diagram. Pathway 
containers that symbolise the detailed pathways should be shown automatically and 
corresponding metabolites and links between them have to be inside those containers. 
The containers are allowed to be overlapping. Pathway containers should be linked to 
corresponding pathways. All of the pathways that belong to each particular larger 
group have to be presented on an outline that corresponds to this group by at least one 
of pathway containers. Additional manual correction should be made if necessary. 
7. The higher level of outlines. Similar approach is used to create the higher level of 
outlines. A list of compounds for the outline has to be generated. The main rule is that 
all of the compounds that appear on the second (less detailed) level outlines have to 
be from the list of the compounds selected for the lower level outlines. In other words, 
gradual hiding the details has to be performed when moving from one level (more 
detailed) to another (less detailed). Moving from a less detailed overview diagram to a 
more detailed one a user should be able to see the same elements (compounds) plus 







Signalling network representation 
 
5.1. Macrophage activation and TNFalpha 
signalling network 
 
After successful application of the Network Representation Framework (NRF) to the 
Edinburgh human metabolic network, the NRF has been also applied to a signal 
transduction network. This section describes macrophage signalling network 
represented using the NRF. The resulting representation consists of detailed diagrams 
and outlines that are united into a single system similarly to the previous example 
from Chapter 4. 
It is not easy to decide how signal transduction events could be subdivided into 
separate outlines as cellular signalling pathways are so intensively interconnected. 
Despite this complexity it is possible to mark out several subnetworks according to 
the most important protein(s) involved in each case. Figure 5.1, the highest level 
outline (PHENOMENOLOGICAL LAYER, LEVEL 3) for the macrophage signalling 
network shows how macrophage is involved into cytokine network. The Macrophage 
signalling network, shown in Figure 5.2 (PHENOMENOLOGICAL LAYER, LEVEL 




TLR, TNF-alpha signalling and IFN-gamma signalling pathways. These in turn can 
be represented in a second biological level of outlines. Figure 5.3 
(PHENOMENOLOGICAL LAYER, LEVEL 1) shows a phenomenological diagram 
of TNF signalling that unites comparatively small biological diagrams (Figures 5.4 -
5.7) comprising the BIOLOGICAL LAYER into a large virtual map. List of 
references for TNF signalling network maps is provided in the references section. 
During the preparation of different signal transduction diagrams, including 
reproducing the Toll-like receptor diagram (Figure 2.4) (Oda and Kitano, 2006) in the 
UN, it was noticed that a particular signalling pathway contains a limited number of 
proteins that are involved in a great number of processes as different states of the 
same protein or as part of complexes. In order to make it easier to deal with signalling 
diagrams in EPE special search plugin has been developed by Richard Adams. The 
basis of the plugin is the fact that if the names of particular proteins/compound/genes 
are specified, all the pathway events could be marked out by using ‘one-step’ 
algorithm, which means that together with all the entities that contain specified names 
all the other entities that are connected to these group via the ‘process’, ‘activation 
link’, ‘logical gates’ or ‘functional gates’ have to be marked out too. 
Another rule in representing signalling pathways in comparison to metabolic 
pathways is to avoid using functional gates (EC numbers). In metabolic pathways, we 
routinely show EC numbers near reactions. On a signalling pathway however, this is 
not so useful. Since phosphorylation is the most common way to change 
protein/complex state, showing EC numbers for signalling event makes the diagram 
unnecessarily complex. In our example diagrams (Figures 5.4–5.7), between 61% and 
100% of reactions are phosphorylation. Therefore in signalling pathways we display 
the EC number only for relationships of type ‘enzyme - metabolic reaction’. 
The modular approach to the organisation of networks has the further advantage of 
promoting the reuse of individual components in different pathways. For example, the 






Figure 5.1. Cytokine network. PHENOMENOLOGICAL LAYER, LEVEL 3. Please 






Figure 5.2. Macrophage signalling network. PHENOMENOLOGICAL LAYER, 





Figure 5.3. TNF signalling network. PHENOMENOLOGICAL LAYER, LEVEL 1. 





Figure 5.4. TNF receptor signalling network. Early events. BIOLOGICAL LAYER. 






Figure 5.5 TNF receptor signalling network. NF-kappa B activation. BIOLOGICAL 






Figure 5.6 TNF receptor signalling network. P38-MAPK and JNK activation. 
BIOLOGICAL LAYER. Please use the CD provided to see a high resolution version 





Figure 5.7 TNF receptor signalling network. Cell death. BIOLOGICAL LAYER. 




5.2. Informal description of proposed 
method for semi-automatic outline 
generation: signalling and gene expression 
events. 
 
The process of semi-automatic outline generation proposed here is similar to the one 
described in section 4.3 for the metabolic network. 
In order to adequately represent the signalling events it was necessary to introduce the 
following additional elements: ‘macromolecule’ (correspond to ‘protein’ or ‘complex’ 
on biological diagram), ‘compound’ (correspond to ‘compound’ on biological 
diagram), ‘RNA’ (correspond to ‘RNA’ on biological diagram) and gene (correspond 
to ‘gene’ on biological diagram). 
1. Preparing the lower level of outlines. Step 1. The lower level of outlines represents 
signalling network as protein-protein interactions. For example, on a detailed 
(biological) diagram (Figure 5.6) unphosphorylated MKK4 is being phosphorylated 
and becomes a new entity – phosphorylated MKK4. MEKK1 activates this process. 7 
different objects represent this event on a detailed diagram: MEKK1, 
unphosphorylated MKK4, phosphorylated MKK4, process glyph, process 
consumption connector, process production connector and activation connector. On 
an outline (Figure 5.3) this step is represented as only 3 objects: MEKK, MKK4 and 
one connector. This way biological diagram can be simplified into protein-protein 
interaction graph. A list of proposed entities for the outlines can be generated 
automatically. The entities that have the same name but different state will be 
represented as one entity on an outline. In the example above unphosphorylated 
MKK4 and phosphorylated MKK4 are split into one entity – MKK4.  
2. Preparing the lower level of outlines. Step 2. On this type of signalling outline a 




abstraction it is irrelevant if any of the proteins are actually part of a complex or if 
there are several states of this protein exist. 
In order to generate an outline from a detailed diagram it is advised to mark the 
macromolecules (proteins, genes, RNAs) that form the main activity flow on the 
detailed map. The list of entities generated during step 1 can be used to simplify this 
process. Then these entities and the relations between them can be picked up by a 
designed for that tool and shown as an outline. Additional manual layout might be 
required at the final stage. 
Similarly to the proposed metabolic outline generation process (Section 4.3), pathway 
containers can be used to represent the pathway and overlapping is allowed in this 
case too (for example, Figure 5.3). 
3. Preparing the higher level of outlines. Each lower level outline should be 
represented by a single shape with corresponding map name (‘pathway container’), 
compounds/proteins/genes/RNAs are shown only as pathway inputs and outputs and 
are linked directly to ‘pathway container’ shape and not to other 
compounds/proteins/genes/RNAs. Connections between different pathways and 
pathway inputs/outputs can be derived automatically based on the information about 
shared elements (compounds/proteins/genes/RNAs or processes) (for example, Figure 
5.2). 
 
Recently a specification for SBGN Activity Flow language (SBGN AF) was 
published (http://www.sbgn.org/Documents/Specifications). We are considering the 
possibility to enable NRF to include SBGN PD and SBGN AF languages. In this case 
SBGN PD will represent the biological layer and SBGN AF will be used as lower 
level outlines. For now it is not clear if automatic translation of SBGN PD language 





5.3. Metabolism regulation: linking 
signalling and metabolic pathways 
Many signalling pathways control metabolic fluxes. On the other hand, the inverse 
control (from metabolic state to signalling pathway) plays a critical role in many 
cellular processes, for instance in the calcium signalling and the inositol signalling 
(Oda and Kitano, 2006).  
However, most metabolic and signalling databases provide a set of maps that focus on 
signalling or metabolic events only. Cases for simultaneous visualisation of both 
hardly exist (e.g. AMPK signalling and Insulin Receptor Signalling (Cell Signalling 
Technology Pathways, http://www.cellsignal.com/pathways/glucose-
metabolism.jsp)). In order to unite the metabolic and signalling networks into a single 
cellular network system, we decided to generate a set of combined maps. The Unified 
Notation allowed us to create the mixed maps and avoid the conflict between different 
styles of metabolic and signalling pathways’ visual representation.  
The use of EC numbers as functional gates in these maps ensures an adequate and 
unambiguous representation even in the cases where visualisation is usually 
confusing. For example, Figure 10 demonstrates the regulation of glycolysis. In this 
pathway,  phosphofructokinase/fructose-2,6-bisphosphatase is a protein that has two 
different activities depending on its phosphorylation state. The phosphorylated form 
of the protein acts as a fructose-2,6-bisphosphatase (EC 3.1.3.46), while the non-
phosphorylated form acts as a phosphofructokinase (EC 2.7.1.105). The diagram 
clearly reflects the multifunctional nature of this protein. 
Figure 5.8 shows regulation of glycolysis by glucagon via the phosphofructokinase 2/ 






Figure 5.8. Regulation of glycolysis by glucagon via phosphofructokinase 2 (PFK2) / 
fructose-2,6-bisphosphatase (F2,6BPase). Please use the CD provided to see a high 




5.4. Additional information visualisation. 
A disease influence on a biological 
network 
By adding certain minor changes to basic diagrams we are able to visualise 
information about changes in biological system related to a disease or other 
influences. To exemplify the result the Cancer Genome Atlas project (Chin, 2008) 
(Pathway analysis of genetic alterations in glioblastoma, 
http://cbio.mskcc.org/cancergenomics/gbm/pathways/) has been used, specifically the 
signalling pathway alterations in glyoblastoma based on mutations and copy number 
changes in 91 samples (Supplementary information, http://www.nature.com/nature/ 
journal/v455/n7216/suppinfo/nature07385.html). Figure 5.9 demonstrates how the 
authors’ (Chin, 2008) original data visualisation could be shown using the symbols of 
the UN. The data is mapped by adding numeric expressions or/and using a designated 
colour scheme.  
Similar representation could be applied to other notations, for example to the SBGN 
PD notation. Corresponding diagrams with SBGN PD notation symbols have been 
produced to illustrate this (Figures 5.10). The ‘identity gate’ symbol has been added 






Figure 5.9. Signalling pathway alterations in Glyoblastoma. 
PHENOMENOLOGICAL (OUTLINE). The UN symbols are used on the outline. 





Figure 5.10. Signalling pathway alterations in Glyoblastoma. 
PHENOMENOLOGICAL (OUTLINE). The SBGN PD symbols are used on the 







Graphical notation survey 
 
6.1. The objectives of the survey 
The main objective of the survey is to show if the notation used in this research has 
any advantages compared to other similar notation used in the field. At the same time 
it would be interesting to compare different notations and see if some features are 
more important for the users than others. Such output could be used later for 
improving graphical notations for biological networks representation. 
The features of the notations to be evaluated in the course of the survey were: 
1) adequacy for metabolism representation, 
2) adequacy for enzyme function, 
3) adequacy for metabolism regulation representation, 
4) adequacy for signalling representation, 
5) readability (how it is easy to read/understand information presented on the 
diagram?) 
6) compactness, 




8) adequacy for gene expression representation, 
9) the number of symbols used (is it sufficient? too many symbols?), 
10) ability to show incomplete and omitted information, 
11) how it is easy to learn the system of symbols. 
Because it was not the priority of this research to evaluate a particular graphical editor 
and taking into account that the additional notations chosen for the survey are not 
supported by EPE, it was decided to prepare a paper version of the survey rather than 
EPE-based version. 
The survey had to evaluate the merits of the several notations. The most natural way 
to do so was  to prepare several pathway diagrams where the same information would 
be presented in different graphical languages for comparative analysis. Because the 
aim of the survey was to receive a feedback on different aspects of the notations, the 




6.2 The choice of the notations for the 
survey 
In this survey, three different notations were used: the SBGN PD language (Le 
Novere, 2009), the mEPN (Freeman, 2010) and the UN (Mazein, in press). The choice 
of the notations to which UN would be compared to was justified according to the 
following criteria:  
1) a notation is developed for describing processes on detailed level;  
2) a notation has to be unambiguous;  




4) the visual languages should be visually easily distinguishable (use different set of 
shapes and ways to represent information);  
It has been decided compare the UN with only two more notations so it would not be 
too difficult to compare them and would not require too much time to complete the 
questionnaire. 
On the basis of the first criterion, for example, MIM notation (Kohn, 2001; Kohn, 
2006; Kohn, 2006) and SBGN ER language (Le Novere, 2009) were excluded from 
the list because they describe relationships between the entities and can not specify 
the order of events on a diagram. SBGN AF language also could not be used because 
it provides ambiguous representation without particular details (Le Novere, 2009). 
Process description language (Kitano, 2005) was not included because its visual 
elements are very similar to the ones of SBGN PD language (criterion 4). 
As a result of this selection process the survey has been restricted to comparing the 
above three notations. 
To provide enough examples for comparison several diagrams were prepared in UN 
and then translated into the other two languages. 
 
 
6.3 The questionnaire 
In order to prepare a better questionnaire the tips on conducting a survey and 
developing a questionnaire were taken into account (for example, Hints for Designing 
Effective Questionnaires, http://pareonline.net/ getvn.asp?v=5&n=3; Questionnaire 
Design, www.cc.gatech.edu/classes/cs6751_97_winterTopics/quest-design/; Survey 
and Questionnaire Design, www.statpac.com/surveys/; How to Write a Survey or 
Questionnaire, www.ehow.com/ how_16596_write-survey-questionnaire.html).  
The final version of the questionnaire is available in Appendix II. 




unobtrusive as possible to the participants, the following constraints were put in place. 
The first section of the questionnaire describes the purpose of the survey and 
introduces the three notations that are being compared. The references for each 
notation are provided. Next section provides brief instructions that explain the format 
of the questions. 
 Some of the questions that could be considered leading are put at the end of the 
questionnaire. This is done, for example, with the question about the importance of 
the ability to show EC on metabolic maps. 
In order to rate a notation the questions had to be as detailed as possible. On the other 
hand, it would not be reasonable to expect each participant be familiar with all the 
aspect and difficulties related to biological information visualisation or would be able 
to learn all three notation quickly enough so they could, for example, actually use 
them to draw a diagram. To overcome this problem, different types of diagrams were 
prepared in all three notations and a respondents were asked to rate how the same 
information is shown in three notations in each of the following cases: metabolic 
pathway representation, signalling pathway representation and so on. More difficult to 
answer questions are placed at the end of the questionnaire. This way the participants 
do not have to learn the notations but still will be able to rate their features. The 
detailed description of the questionnaire is provided in section 8.6. 
To ensure the  objectiveness and quality of the results, we restricted the survey in the 
following respects :. 
1. All the participants of the final version of the survey were from outside the research 
group. More details can be found in section 6.5. 
2. Developing and everyday use of different graphical languages for representing 
biological knowledge is a particular area of expertise. We could not expect the 
participants to be familiar with all the graphical languages used in the survey. At the 
same time, it was important to ensure that the participants can actually read and 
understand biological information represented on the questionnaire’s diagrams.  
That is why it was decided to include a simple test that would demonstrate the 




was not done correctly were excluded from the dataset. 
3. To make the comparison easier and impartial, colours were excluded from the 
diagrams. 
4. In all cases diagrams represent exactly the same biological events. If there were any 
differences in the information presented that relates only to an ability of a particular 
notation to show certain type of data. 
 
 
6.4 The survey pre-test 
The first version of the survey can be found on the CD enclosed. 12 students of the 
Systems Biology Course 2009/2010 (University of Edinburgh, School of Informatics) 
were offered to complete the questionnaire after they had learned how to use different 
graphical languages including those used in the survey. 
This version of the survey consists of two different parts. The first part contains 
several pathways represented in the 3 notations and responders had to write their 
comments on each diagram. The second part offered to evaluate each notation listing 
their features such as readability, complex representation, metabolism representation, 
signalling representation, gene expression representation, number of symbols used 
and the ability to represent incomplete knowledge. At the end the students had to add 
three more features they considered to be important and rate them for each notation. 
The final task was to list strong points and weaknesses for each of the notations. 
Later the content of this version of the survey was discussed with the students in order 
to see if there were any unclear or misleading questions or suggestions on how the 
questionnaire could be improved. 
The main concern was about the fact that it generally took too long for the students to 
complete the questionnaire: 45-90 minutes. This was mainly because in the first part 




free form and compare as many features as possible. 
During the analysis of the results of pre-survey it became clear that it is difficult to 
deal with the feedback which is provided in different formats for different questions. 
For most of the questions it was necessary to provide rating using the scale from 1 to 
10 and for some questions 4 options of answers were offered and the participants had 
to choose one. As the answers were given in different format it would be necessary to 
prepare different types of excel file templates and different types of graphs for 
visualising the results and that could cause unnecessary complications both in analysis 
and representing. 
On the next stage another version of the questionnaire was prepared in the way so it 
would take approximately 20-30 minutes to complete it.  
In the final version all the ratings were done on the scale from 1 to 10, where 1 is the 
most negative mark and 10 is the most positive assessment of a notation feature. 
Open-ended questions were excluded from the final version of the questionnaire to 
make it easier to analyze the results. 
The survey pre-test helped to significantly improve the quality of the questionnaire 
and made the final version much easier to complete without noticeable decrease in 
information value of the survey. 
. 
6.5 The survey results 
The participants of the survey were: M.Sc. students of biological and informatics 
courses at the University of Edinburgh (61 completed the questionnaire, 15 with 
incorrect test), Ph.D. students in biology and in bioinformatics at the University of 
Edinburgh (25 completed the questionnaire, 4 with incorrect tests), participants of the 
COmputational Modeling in BIology Network meeting in Edinburgh in October 2010 
(COMBINE 2010, http://sbml.org/Events/Forums/COMBINE_2010) (18 completed 
the questionnaire, in all cases the test was correct) and attendants of the 11th 




2010, http://www.icsb2010.org.uk) (8 completed the questionnaire, 1 with incorrect 
test). 
Total number of the returned completed questionnaires was 112. In 20 cases the test 
was incorrect and those questionnaires were excluded from the dataset. These answers 
are considered to be correct in the test (Appendix II): 
Protein A activates protein B   FALSE 
Protein B activates protein C   FALSE 
Protein A activates protein C   TRUTH 
Protein D activates protein C   TRUTH 
Protein A inhibits protein D  FALSE or NOT SURE 
The results described in this section are based on the 92 completed questionnaires 
with correct test. 
Data from the questionnaire sheets were combined into an Excel file that can be found 
on the CD (\Survey\survey.results.xls). Average value and standard deviation value 
was calculated for each rating. For that such Excel functions as CALCIF, AVEGARE 
and STDEV were used. On the diagrams bellow (Figures 6.1-6.11) the average value 
is represented by a column and the standard deviation value is shown for each 
column. 
A plot with a distribution of the answers for each notation has been created (Appendix 
III). Small extra peak around ratings 5 and 6 has been considered insignificant 
because ratings 5 and 6 were reserved for answer ‘not sure’ and the peak can signify 
the number of participant that were not sure how to answer the question. 
Although it was not possible to quantify the comments, in cases when the major 
number of comments for a particular rating point was given toward the same issue, 
this issue is discussed in the section that corresponds to that rating. 





6.5.1. Metabolism representation 
The average rating for the mEPN (8.5) in category ‘metabolism representation’ is 
noticeably higher than the average ratings for the SBGN PD (6.8) and the UN(7.2). 
Since for this category only metabolites and processes are shown on the example 
diagram, and because the process representation is very similar in all the three cases 














Figure 6.1. The average ratings for metabolism representation. 
According to the results, the mEPN provides the best representation of metabolic 




6.5.2. Enzyme function representation 
The UN has significantly higher rating for this feature (Figure 6.2) compared to the 
other two notations. We assume that this is because ECs can be shown in the UN in 
familiar, similar to KEGG (Kyoto Encyclopaedia of Genes and Genomes, 
www.genome.jp/kegg) representation. The newly introduced entity ‘functional gate’ 
allows one to show the EC and protein name without any difficulties simply because 
they are shown as different entities. In the UN an enzyme function is clearly separated 
form ‘protein’ of ‘complex’ entity. Using ‘functional gate’ it is easy to assign one EC 
to several entities, or show several EC to visualise multiple functions of a single 
protein or complex. The example ‘Phosphatidylinositol metabolism’ offered for 




















6.5.3. Metabolism regulation representation 
The UN has higher average rating in this category (8.4 in contrast to 6.6 and 6.4 for 
the other two notations) (Figure 6.3). The ‘functional gate’ entity offers the most 
consistent representation. In order to add signalling events to a metabolic diagram 
(see ‘Glycolysis regulation’ example in Appendix II) a user does not need to change 
metabolic diagram but only needs to add new entities to describe regulation. 
For example in SBGN PD the enzyme function (EC) can be shown on a metabolic 
diagram as proteins but then the EC has to be replaced by the protein name when 
singnalling events are added. That makes enzyme function representation 
inconsistent. It is also impossible to show multiple enzyme functions in cases when 
there are several enzymological activities assigned to one protein or complex. 
Similarly to SBGN PD mEPN can display EC only as an alternative name for the 




















6.5.4. Signalling representation 
The example for this category, MAPK cascade, was chosen so that it would be 
possible to evaluate the newly introduced ‘multistate’ entity of the UN. In contrast 
with our expectation most of the users gave the UN representation comparatively low 
rating (average rating 6.2) (Figure 6.4). According to the answers’ distribution 
(Appendix III, Part 4, Figure Q4C) most of the responders could not rate this feature 
for the UN in a definitive way. Most of them rated the UN 5 and 6 (‘not sure’). We 
conclude that the responders found this representation confusing and less convenient 
compared to the representations offered by the other two languages. 
According to this survey the most convenient representation of signalling events with 
very high rating 9.0 was the one offered by SBGN PD language (Figure 6.2). The way 
the SBGN PD represents macromolecules and their states is different from the other 




















The SBGN PD provides the best readability according to the Figure 6.5. 
Comparatively low average value for the mEPN probably is due to the number of 
different types of processes that are reserved in this notation (please see the mEPN 




















None of the language has been singled out in this category (Figure 6.6) That is either 
because the notations offer similar level of compactness, or the size of the diagrams 
offered for comparison for evaluating this feature was not large enough for the 




















6.5.7. Complex representation 
The SBGN PD language was chosen as the most convenient notation for complex 
representation (Figure 6.7). All three language show rating 6.8 and higher which 


















6.5.8. Gene expression representation 
The result for gene expression show that all the three notations have comparatively 
similar ability for successful representation of gene expression events (average rating 



















6.5.9. Number of symbols 
While the SBGN PD and the UN were evaluated as notations with sufficient number 
of symbols, the mEPN was marked out as a notation ‘with too many or too few’ 



















6.5.10. Ability to represent incomplete or omitted information 
The results in this category are inconclusive. None of the notations have been singled 
out (Figure 6.10). The average rating is higher that 5. It is interesting that a significant 
number of responders found it difficult to answer this question definitively (see Part 




















8.7.11. Is it easy to learn/remember the system of symbols? 
The users described the UN as the most easy-to-learn language and the mEPE as the 



















6.5.12. Is compactness an important feature of a graphical language? 
A significant number if responders did not find the ‘compactness’ feature to be 
important, 25% were not sure and 58% believed this feature is important (Figure 
6.12). According to several responders’ comments, even despite it might be useful to 
be able to represent a network in compact way, this feature can not be treated as the 
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NO NOT SURE YES
 
Figure 6.12. A. The distribution of the answers for the question about the importance 
of the compactness feature. B. The discrete distribution of the answers for the 
question about the importance of the compactness feature. Ratings from 1 to 4 are 
aggregated together under the first column (NO), ratings 5 and 6 are – under the 







6.5.13. Is it important to be able to show the ECs on a metabolic diagram? 
67.5% of the responders have answered to this question positively. A significant 
number of answers falls into ‘not sure’ category (Figure 6.13). According to their 
comments, some of the respondents want to be able to show not only the EC but also 
the enzyme name or corresponding gene name. Several comments pointed out that it 
is not always easy to determine a EC number even though the question was about the 
ability to show EC which not necessarily meant that a user has to determine a EC in 









1 3 5 7 9










NO NOT SURE YES
 
Figure 6.13. A. The distribution of the answers for the question about the importance 
of the ability to show EC on a metabolic diagram. B. The discrete distribution of the 
answers. Ratings from 1 to 4 are united and represented by the first column (NO), 
ratings 5 and 6 are – by the second column (NOT SURE) and ratings from 7 to 10 – 




6.5.14. Is it important to be able to represent generic-specific relationships on a 
diagram? 
57.6% of the participants think it is important to be able to represent generic-specific 
relationships on a diagram. 39.1 % were not sure how to answer (Figure 6.14), 
probably because they were not familiar with this problem and were not sure about 
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NO NOT SURE YES
 
Figure 6.14. The distribution of the answers to the question about the importance of 
the ability to show EC on a metabolic diagram. B. The discrete distribution of the 
answers. Ratings from 1 to 4 are summarized and represented by the first column 
(NO), ratings 5 and 6 are – by the second column (NOT SURE) and ratings from 7 to 




6.5.15. ‘Label outside the shape’ or ‘label inside the shape’? 
Most of the responders (82%) have decided in favour of ‘label inside the shape’ 
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OUTSIDE NOT SURE INSIDE
 
Figure 6.15. A. The distribution of the answers on the question whether the label 
should be shown inside of outside the shape. B. The discrete distribution of the 
answers for the question about the importance of the ability to show EC on a 
metabolic diagram. Ratings from 1 to 4 are summarized and represented by the first 
column (OUTSIDE), ratings 5 and 6 are – by the second column (NOT SURE) and 





The table 6.1 summarizes the most important results of the survey and provides brief 
interpretation of the results: 
• In the mEPN ‘simple biochemical’ entity is well represented. As the approach 
to the label representation in the mEPN is similar to the SBGN PD, the ‘label 
inside the shape’, new version of the SBGN PD language could benefit from 
changing the shape from a circle to a more convenient form. 
• The UN provides a consistent and convenient way to represent enzyme 
function. The consistency is ensured using the ‘functional gate’ entity which 
allows visualising EC in the same way on different types of maps. For 
example, in current version of the SBGN PD it is possible to show EC as a 
name of the ‘macromolecule’ entity, but in case when actual protein name has 
to be represented, it is impossible to show EC any more. 
• The new entity ‘functional gate’ ensures the most convenient way to link 
signalling and metabolic events on metabolism regulation diagrams. 
• The new entity ‘multistate entity’ does not provide a better representation. 
Removing this entity from the UN’s set of symbols has to be considered. 
• The SBGN PD provides the most easy-to-read representation. mEPN has too 
many symbols and that makes it difficult to read the diagrams in this notation. 
• The SBGN PD provides the most convenient complex representation. 
• The SBGN PD provides the most convenient signalling events representation 
(macromolecule representation, state variable representation). 
• The number of symbols used in the mEPN has to be reduced in order to make 
it more successful notation. That would also make the mEPN system of 
symbols easier to learn. 
• Compactness is an important feature of a graphical language. On the other 
hand, according to some of the respondents’ comments, it is not the most 
important feature. 
• Most of the users would like to be able to show EC on metabolic diagrams. 
• It is important to be able to represent ‘generic-specific’ relationships. The UN 
is the only notation that enables a user to do that. 
‘Label outside the shape’ approach used in the UN has to be reconsidered as most 





Table 6.1. Interpretation of the survey results 
QUESTION KEY WORDS SBGN PD MEPN UN INTERPRETATION 
Q1 metabolic 6.8 8.5 7.2 
mEPN: well-represented simple chemical 
New shape for compounds should be introduced in the SBGN PD 
Q2 EC 6.4 6.3 8.4 UN: consistent way to represent enzyme function 
Q3 regulation 6.6 6.4 8.4 UN: functional gate to link metabolism and signalling 
Q4 signalling 9.0 7.9 6.2 
UN: confusing representation (multistate entity)  
SBGN PD: well-represented signalling events 
Q5 readability 8.3 6.2 7.3 mEPN: too many types of the ‘process nodes’ 
Q6 compactness 6.6 6.4 6.5 Results are inconclusive 
Q7 complex 8.2 7.1 6.8 SBGN PD: well-represented complex 
Q8 gene expression 7.3 7.1 7.2 Results are inconclusive 
Q9 number of symbols 7.6 4.2 7.0 mEPN: too many symbols 
Q10 incomplete knowledge 6.4 6.3 6.4 Results are inconclusive 
Q11 learning 7.3 4.8 8.3 mEPN: difficult to learn. UN: easy to learn 
Q12 compactness issue no 17%, not sure 25%, yes 59% Compactness is an important feature of a notation 
Q13 EC visualisation issue no 7%, not sure 26%, yes 68%  It is important to be able to show EC 
Q14 ‘generic-specific’ issue no 3%, not sure 39%, yes 58%  Representing generic-specific is important 
Q15 label position issue outside 13%, not sure 4%, inside 82% “Label outside the shape” approach in UN should be reconsidered 
 
One of the important outcomes of the survey was the evaluation of the features of 
different graphical languages that allowed us to determine those most usable (from user’s 
point of view). The list of approved/desired features that were identified as the result of 
comparable analysis of the three notations is given below: 
1. Simple chemical representation by the mEPN, 
2. Complex representation by the SBGN PD, 
3. Well-represented signalling events in the SBGN PD, 
4. A consistent way to represent enzyme function in the UN, 
5. Minimal efficient set of symbols in the UN, 
6. Easy-to-learn features of the UN, 
7. Generic-specific entities representation provided by the UN. 
The result of the survey showed that the UN has new features currently not available in 
other notation that allow improving usability of graphical representation for cellular 
networks. 
 
The described in this chapter survey addresses only one of the two main subjects of this 
research, namely, the system of symbols designed for unambiguous network 
representation. It would be also desirable to evaluate the usability of the Network 
Representation Framework. In order to make meaningful evaluation of this type, the 
framework should actually be used by an expert in context of a graphical network editor 
for a particular task and would require significant amount of work. Unfortunately, this 
kind of resource for usability evaluation is not currently available. 
The next section discusses the attempt to put together the useful users’-approved features 





Proposed new entities for SBGN PD 
language 
 
As part of the SBGN community efforts to develop SBGN languages, a workshop series 
were initiated in 2006. SBGN 6 meeting took place in Edinburgh in 2010 and was part of 
the COMBINE meeting (COmputational Modeling in BIology Network, 
http://sbml.org/Events/Forums/COMBINE_2010). 
Reviewing SBGN PD language features and preparing diagrams in SBGN PD language I 
came to conclusion that despite the SBGN PD notation is very well developed, it has 
some disadvantages, mainly in the area of metabolism representation. I felt that the 
SBGN PD language could benefit from adopting those features of the UN that are related 
to metabolism representation, in particular, ‘functional gate’ and ‘identity gate’. 
Corresponding proposal was prepared and introduced as an oral presentation during the 
COMBINE meeting (Mazein A. Metabolic Network Representation in SBGN PD: EC 
and Identity Gate, COMBINE 2010, 06 October 2010, http://precedings.nature.com/ 
documents/4974/version/1). The proposal was further discussed after the COMBINE 
meeting as part of SBNG discussion (Nicolas LeNovere, personal communication, 2010). 
The proposal is described in the next three sections. 
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7.1 The new shape for metabolites. 
Most metabolic compounds have long names compared to the names of proteins where 
mainly abbreviations are used. It is not easy to fit a long name into a circle shape reserved 
for the “small molecule” entity in SBGN PD (SBGN, www.sbgn.org).  
There are several possible solutions: 
• applying the approach used in the UN “name-outside-the-shape” (this is not 
allowed in SBGN PD and would make the notation inconsistent); 
• making circles large enough so the name would fit the shape (this solution would 
require a lot more space); 
• replacing long compound names by short names (this solution would require 
changing thousands of names in case of genome-scale metabolic network 
visualisation; a list of abbreviations would require to be enclosed with each 
metabolic map); 
• using comparatively small circles and allowing part of the name to be outside the 
shape (this solution was used by Falk Schreiber, the winners of the SBGN annual 
competition in 2010 (http://www.sbgn.org/Competition); 
• changing the shape from circle to a more convenient shape (this solution is 
proposed here).  
The second best solution is using comparatively small circles and allowing a part of the 
name be outside the shape (Figure 7.1, A). In this case no changes in SBGN PD language 
would require. The problem with this solution is that having a part of the name outside a 
compound shape makes it extremely difficult to use horizontal connectors as in SBGN 
PD the link have to go to the edge of a shape and a horizontal links are not allowed to 
cross the name (Figure 7.1, B) according to the SBGN PD rules (SBGN PD Level 1 
Version 1.2 specification, http://www.sbgn.org/Documents/Specifications). Then the only 
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solution is using several bend points (Figure 7.1, C). This problem becomes even more 
difficult to avoid in cases of a very busy network (Figure 7.2). 
Proposed here solution is to change the shape for the “small molecules” entity. An 
example with a new shape is shown in Figure 7.3. A new shape is used instead the current 









Figure 7.1. Metabolic reaction representation in SBGN PD. A. Using comparatively small 
circles and allowing a part of the name be outside the shape. B. Forbidden representation 
in SBGN PD. C. Possible solution for representing horizontal links in the current version 





Figure 7.2. A fragment of Phosphatidylinositol pathway map in the UN. In this example a 
compound is connected to other compounds by 10 links, and 5 of them are horizontal. In 






Figure 7.3. A new shape for the “small molecule” entity of SBGN PD language. The 
shape accommodates the name of the entity. This way horizontal links can be used 




7.2 Using EC as a functional gate 
EC is the most compact way to show enzymological function on a 
metabolic/signalling/metabolism regulation diagram. In cases when several EC numbers 
are assigned to one reaction, or one protein/complex has several activities (ECs), it is 
impossible to show the enzyme function without using an additional symbol.  
The currently used representation in SBGN PD uses ‘macromolecule’ entity with EC as a 
name. For example the glycolysis diagram available from SBGN website (SBGN PD 
examples, http://sbgn.org/Documents/PD_L1_Examples). EC is shown as a generic 
protein that could actually be not only a protein but also a multimer or a complex.  
Another problem is inconsistency in representation. As soon as an actual protein name 
has to be shown the EC can not be shown any more (Figure 7.4). 
The same example is shown on Figure 7.5 with the proposed ‘functional gate’ entity. 
‘Functional gate’ entity is represented by a special glyph which has to be placed on the 
link between a protein/complex and a reaction. One or more outputs are possible. No 
input, one or many inputs are allowed. 
One of the important features of the new entity is that it can be used on its own on maps 
were only metabolites and EC need to be shown; and it can be linked to a particular 
proteins on more complicated maps (metabolism regulation, signalling). 
 152
Another example represents the cases when one protein can catalyze two reactions and 
when one reaction is being catalyzed by several proteins with the same enzymological 




Figure 7.4. Inconsistent EC representation in SBGN PD. A fragment of Glycolysis 
pathway. Most of the enzymes are shown as generic protein entity. Bifunctional enzyme 
PFK2/2,6BFase visualized without its two enzymological functions shown as EC. Please 





Figure 7.5. Using EC as a special glyph ‘functional gate’. A fragment of Glycolysis 
pathway. Please compare to Figure 9.4. Both the enzyme functions (2.7.1.105 and 
3.1.3.46) of the protein PFK2/2,6BFase are shown without any difficulties. 
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Figure 7.6. A fragment of Phosphatidylinositol pathway map shown in the modified 
SBGN PD language. ‘Functional gate’ entity is used to show EC. 
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7.3 Identity gate 
In the current version of SBGN PD there is no specific way to connect generic entity to 
particular specific entities on a diagram (SBGN PD Level 1 Version 1.2 specification, 
http://www.sbgn.org/Documents/Specifications). 
The “identity gate” glyph is proposed to connect a generic and corresponding specific 
entities. A circle with symbol “≡“ in it can be used for this entity. Only one output is 
allowed, multiple inputs are possible. 
Figure 9.7 shows an example where ‘identity gate’ is used to show the relationships 
between soluble and membrane forms of TNFalpha. Both soluble and membrane forms 
can activate TNFR1, but only the membrane form can activate TNFR2. Using “identity 
gate” is the only way to show such a case on a single diagram. Generic TNFalpha would 
be used as TNFR1 activator, mTNFalpha – as TNFR2 activator; and it would be possible 
to show relationships between sTNFalpha, mTNFalpha and generic TNFalpha. 
Using identity gates potentially might cause ambiguity on a diagram. An example of such 
case is shown on Figure 7.8.  
To avoid ambiguity until this issue is resolved I would like to propose a set of rules that 
would allow using ‘identity gates’ in limited number of cases.  
Rule 1. It is safe if there is only one ‘identity gate’ one a map (Figure 9.7). 
Rule 2. It is safe if the map does not include any processes but only ‘identity gates’ and 
related entities are shown (Figure 9.9). 
Rule 3. It is safe if several generic entities (with corresponding ‘identity gates’) are used 
only as inputs in the processes and are not used as outputs. In other words, it is safe if two 
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generics (with corresponding identity gates) are not connected via one or several 
processes in the way that one is an input and another is an output (Figure 9.10). 
The currently proposed entity is discussed as ‘identity operator’ and it is not clear if it is 
going be a part of entity pool node set in SBGN PD (‘identity operator’), a part of the 






Figure 7.7. Using proposed ‘identity gate’ entity. Both soluble sTNF-alpha and 
membrane mTNF-alpha  forms can activate TNFR1. Generic entity TNF-alpha is used to 
show that. Only membrane form can activate TNFR2. 
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Figure 7.8. Incorrect using of the ‘functional gate’ entity. On the diagram an attempt is 
made to show that 1A specific entity transforms into 2A specific entity, but not to 2B or 
2C. On the other had the reader can assume that any of the transformations are possible. 




Figure 7.9. Fatty acid generic chart. The scheme represents relationships between generic 




Figure 7.10. Illustration of using rule 3 of representing ‘identity gate’. Generics 1 and 2 
that are connected each to corresponding ‘identity gate’. Generics 1 and 2 are used only 








In this research the most powerful features of the existing approaches have been 
considered alongside with newly proposed techniques. Two extensive examples show 
how a complex network can be efficiently represented at several levels of detail. A new 
notation, the UN, has been evaluated against the SBGN PD language and mEPN during 
the user survey. The results have suggested us to consider the exclusion of the 
unsuccessful features, while keeping the most useful ones.  
The survey results have also indicated that it is desired that a consensus visual language 
should comply with the following two criteria in order to be both user-friendly and able 
to represent cellular network unambiguously: minimal number of easy-to-learn symbols 
and consistency in representation between different levels and aspects of network 
representation.  
Individual points and results of the current research are listed below: 
1. Existing techniques of biological network representation have been reviewed and the 
strongest features were selected for inclusion when developing a new representation 
system. 
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2. New graphical language has been developed and is introduced here as the Unified 
Notation. The most distinctive features of the UN are: minimal number of symbols 
sufficient for representing cellular networks, the ‘label outside the shape’ 
visualisation, compactness of network representation, ‘functional gate’ entity, 
‘multistate’ entity and ‘identity gate’ entity. The last three entities are used only in the 
UN and were introduced in order to improve the notation usability.  
3. The new representation system, the Network Representation Framework, enables 
managing large cellular networks by organising the diagrams on multiple levels of 
details and multiple levels of constraints. This thesis proposes using comparatively 
small ‘basic’ diagrams represented in unambiguous notation. The outline diagrams 
unite these basic diagrams into a single large-scale virtual map. 
4. In order to test the capabilities of the new features, large-scaled examples have been 
developed:  
a) the Edinburgh Human Metabolic Network representation;  
b) the TNF-alpha receptor network representation 
The ‘Glycolysis regulation’ example demonstrates the ability of the UN to represent 
events from different domains (metabolic and signalling) on a single diagram. 
5. The Graphical notation survey has been carried out that allowed to obtain user 
feedback on the features of new visualisation language. The UN has been compared 
with the SBGN PD and mEPN languages. The results of the survey have showed that 
while using ‘label outside the shape’ approach and the ‘multistate’ entity should be 
reconsidered, such features of the UN as ‘functional gate’ and ‘identity gate’ entities 
were deemed a welcome addition. 
6. The new features of the UN ‘functional gate’ and ‘identity gate’ have been adopted 
for SBGN language and alongside with proposed new shape for ‘simple chemical’ 
entity offered for consideration for the new version of SBGN PD language. 
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Future work 
I would like to continue working on improving the techniques used for representing 
cellular networks. A new version of the UN is going to be developed and its features will 
be changed according to the results of the survey in order to provide better usability and 
network representation. 
If most adventurous features of the UN such as the ‘functional gate’ and ‘identity gate’ 
are accepted for the next version of SBGN PD language, in addition to the UN we are 
planning to use the SBGN PD on the detailed level of the NR representation and propose 
a algorithm for translation between the SBGN PD and SBGN AF languages in order to 
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Appendix II. Graphical Notation Survey 
 
 
Graphical Notations Survey 
 
Reasons to complete this questionnaire: 
 
• the questionnaire includes useful examples of metabolic, 
signalling and gene expression events visualization 
• make yourself familiar with several visual languages at 
the same time 
• the result of these survey will help developing and 




This survey compares three graphical languages: 
Systems Biology Graphical Notation Process Description (SBGN PD) (Le Novere et al, 2009) 
Modified Edinburgh Pathway Notation (mEPN) (Freeman et al, 2010) 




Depends on the level of expertise the questionnaire will take from 20 to 30 min 
 
References: 
Le Novere N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E, Wegner K, Aladjem MI, 
Wimalaratne SM, Bergman FT, Gauges R, Ghazal P, Kawaji H, Li L, Matsuoka Y, Villeger A, Boyd SE, 
Calzone L, Courtot M et al (2009) The Systems Biology Graphical Notation. Nat Biotechnol 27: 735-741 
 
Freeman TC, Raza S, Theocharidis A, Ghazal P. (2010) The mEPN scheme: an intuitive and flexible 
graphical system for rendering biological pathways. BMC Syst Biol, Vol. 4, p. 65. 
 
Mazein A, Sorokin A, Adams R, Moodie S, Golyanin I (2011) Visual Knowledge Management. 
International Journal of Knowledge Engineering and Data Mining (IJKEDM), (in press) 
 
Test 
So that the results of this questionnaire can be included into the dataset please 
complete the test bellow: 
 
Please circle the correct answers that correspond to the diagram. 
 
Protein A activates protein B  TRUTH       FALSE      NOT SURE 
Protein B activates protein C  TRUTH       FALSE      NOT SURE 
Protein A activates protein C  TRUTH       FALSE      NOT SURE 
Protein D activates protein C  TRUTH       FALSE      NOT SURE 








While answering the questions in the survey please refer to the legends on the last page. 
 
In each section you will find that same events are represented in three different graphical 
notations. Please first take a look at all three diagrams, compare them and after that rate the 
features of the notations. 
 
Please rate your answers as follows: 
 
 
Strongly disagree  1  2  Disagree  3  4  5  6  Not sure  7  8  Agree  9  10  Strongly agree 
 
 
For example, if strongly disagree please circle 1 and if strongly agree please circle 10, if not sure 
circle 5 or 6. 
 
You should spend approximately 2 minutes on each of the next 4 pages and approximately 4-6 
minutes on each of the last 3 pages. 
 
If you notice that any of the languages is misrepresented or there are mistakes in using the 
notation, please comment on the corresponding diagram.  
 
 
Please return the questionnaire by 1st November 2010.  
 
Please send the complete questionnaire by email or post using contact information bellow. 
 
Email: Alexander Mazein a.mazein@sms.ed.ac.uk 
Address: Alexander Mazein, University of Edinburgh, Informatics Forum - Room 1.43,  









     
   




How would you rate METABOLIC PATHWAY 
representation in this notation? 
 




How would you rate METABOLIC PATHWAY 
representation in this notation? 
 




How would you rate METABOLIC PATHWAY 
representation in this notation? 
 












How would you rate ENZYME FUNCTION 
representation in this notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
 
How would you rate ENZYME FUNCTION 
representation in this notation? 
 




How would you rate ENZYME FUNCTION 
representation in this notation? 
 


















   




How would you rate the representation of 
METABOLISM REGULATION in this notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
How would you rate the representation of 
METABOLISM REGULATION in this notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
 
How would you rate the representation of 
METABOLISM REGULATION in this notation? 
 
















   




How would you rate SIGNALLING representation 
in this notation? 
 




How would you rate SIGNALLING representation 
in this notation? 
 




How would you rate SIGNALLING representation 
in this notation? 
 












Is it easy to read and understand the diagram? 
 
Very difficult  1  2  3  4  5  6  7  8  9  10  Very easy 
 
 
How would you rate COMPACTNESS of this 
notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
 
How would you rate COMPLEX representation in 
this notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
 
How would you rate GENE EXPRESSION 
representation in this notation? 
 





Is it easy to read and understand the diagram? 
 
Very difficult  1  2  3  4  5  6  7  8  9  10  Very easy 
 
 
How would you rate COMPACTNESS of this 
notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
 
How would you rate COMPLEX representation in 
this notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
 
How would you rate GENE EXPRESSION 
representation in this notation? 
 






Is it easy to read and understand the diagram? 
 
Very difficult  1  2  3  4  5  6  7  8  9  10  Very easy 
 
 
How would you rate COMPACTNESS of this 
notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
 
How would you rate COMPLEX representation in 
this notation? 
 
Extremely poor  1  2  3  4  5  6  7  8  9  10  Excellent 
 
 
How would you rate GENE EXPRESSION 
representation in this notation? 
 




How would you rate the NUMBER OF SYMBOLS 
used in this notation? 
 
Too few 
or too many 1  2  3  4  5 6  7  8  9  10 Sufficient 
 
How would you rate ability of this notation to 
represent INCOMPLETE/OMITTED information? 
 
Too few 
or too many 1  2  3  4  5 6  7  8  9  10 Sufficient 
 
Would you agree that it is fairly easy to 
LEARN/REMEMBER this system of symbols? 
 
Strongly  








How would you rate the NUMBER OF SYMBOLS 
used in this notation? 
 
Too few 
or too many 1  2  3  4  5 6  7  8  9  10 Sufficient 
 
How would you rate ability of this notation to 
represent INCOMPLETE/OMITTED information? 
 
Too few 
or too many 1  2  3  4  5 6  7  8  9  10 Sufficient 
 
Would you agree that it is fairly easy to 
LEARN/REMEMBER this system of symbols? 
 
Strongly  











How would you rate the NUMBER OF SYMBOLS 
used in this notation? 
 
Too few 
or too many 1  2  3  4  5 6  7  8  9  10 Sufficient 
 
How would you rate ability of this notation to 
represent INCOMPLETE/OMITTED information? 
 
Too few 
or too many 1  2  3  4  5 6  7  8  9  10 Sufficient 
 
Would you agree that it is fairly easy to 
LEARN/REMEMBER this system of symbols? 
 
Strongly  







Would you agree that the compactness is an important feature of a graphical 
language? 
 








Would you agree that it is important to be able to show EC numbers on a metabolic 
or metabolism regulation diagram? 
 








Would you agree that it is important to be able to represent GENERIC-SPECIFIC 
RELATIONSHIPS on a diagram? Example of generic entity: “amino acid”. 
Corresponding specific entities are particular amino acids, for example alanine, 
serine etc. 
 








What type of representation do you prefer: “label outside the shape” or “label inside 
the shape”? 
 









Thank you  

















1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 










1 3 5 7 9
 









1 3 5 7 9
 









1 3 5 7 9
 
Figure Q11C. A plot of the UN rating distribution 
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